Chemotherapy with cetuximab in head and neck squamous cell carcinoma: immunological aspects and markers of treatment effectiveness in clinical practice ; Химиотерапия на фоне таргетной терапии цетуксимабом при плоскоклеточном раке органов головы и шеи: иммунологические аспекты и маркеры эффективности в клинической практике

Συγγραφείς: A. I. Stukan, S. I. Kutukova, E. A. Nefedova, V. A. Porkhanov, V. N. Bodnya, T. Yu. Semiglazova, N. A. Tsygan, V. V. Kudrina, I. I. Aseeva, Yu. Yu. Stefanova, A. A. Kurmanaliev, M. A. Chagiev, А. И. Стукань, С. И. Кутукова, Е. А. Нефедова, В. A. Порханов, В. Н. Бодня, Т. Ю. Семиглазова, Н. А. Цыган, В. В. Кудрина, И. И. Асеева, Ю. Ю. Стефанова, А. А. Курманалиев, М. А. Чагиев

Πηγή: Head and Neck Tumors (HNT); Том 14, № 1 (2024); 16-30 ; Опухоли головы и шеи; Том 14, № 1 (2024); 16-30 ; 2411-4634 ; 2222-1468 ; 10.17650/2222-1468-2024-14-1

Θεματικοί όροι: плоскоклеточный рак головы и шеи, targeted therapy, cetuximab, systemic inflammation, head and neck squamous cell carcinoma, таргетная терапия, цетуксимаб, системная воспалительная реакция

Περιγραφή αρχείου: application/pdf

Relation: https://ogsh.abvpress.ru/jour/article/view/965/616; Vermorken J.B., Trigo J., Hitt R. et al. Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. J Clin Oncol 2007;25(16):2171-7. DOI:10.1200/jco.2006.06.7447; Langer C.J. Targeted therapy in head and neck cancer: state of the art 2007 and review of clinical applications. Cancer 2008;112(12):2635-45. DOI:10.1002/cncr.23521; Guigay J., Auperin A., Fayette J. et al. Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as frst-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial. Lancet Oncol 2021;22(4):463-75. DOI:10.2139/ssrn.3700967; Mirabile A., Miceli R., Calderone R.G. et al. Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck. Head Neck 2019;41(6):1895-902. DOI:10.1002/hed.25636; Schlessinger J. Receptor tyrosine kinases: legacy of the first two decades. Cold Spring Harbor Perspect Biol 2014;6(3):a008912. DOI:10.1101/cshperspect.a008912; Yarden Y., Pines G. The ERBB network: at last, cancer therapy meets systems biology. Nat Rev Cancer 2012;12(8):553-63. DOI:10.1038/nrc3309; Zhang X., Gureasko J., Shen K. et al. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 2006;125(6):1137-49. DOI:10.1016/j.cell.2006.05.013; Lemmon M.A., Schlessinger J., Ferguson K.M. The EGFR family: not so prototypical receptor tyrosine kinases. Cold Spring Harbor Perspect Biol 2014;6(4):a020768. DOI:10.1101/cshperspect.a020768; Lemmon M.A., Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2010;141(7):1117-34. DOI:10.1016/j.cell.2010.06.011; Trivedi S., Concha-Benavente F., Srivastava R.M. et al. Immune biomarkers of anti-EGFR monoclonal antibody therapy. Ann Oncol;41(5):678-84. DOI:10.1093/annonc/mdu156; Li S., Schmitz K.R., Jeffrey P.D. et al. Structural basis for inhibition of the epidermal growth factor receptor by cetuximab. Cancer Cell 2005;7(4):301-11. DOI:10.1016/j.ccr.2005.03.003; Bhat R., Watzl C.J.P. Serial killing of tumor cells by human natural killer cells - enhancement by therapeutic antibodies. PLoS One 2007;2(3):e326. DOI:10.1371/journal.pone.0000326; Srivastava R.M., Lee S.C., Andrade Filho P.A. et al. Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients. Clin Cancer Res 2013;19(7):1858-72. DOI:10.1158/1078-0432.ccr-12-2426; Gabrilovich D.I., Ostrand-Rosenberg S., Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012;12(4):253-68. DOI:10.1038/nri3175; Ostrand R.S. Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity. Cancer Immunol 2010;59(10):1593-600. DOI:10.1007/s00262-010-0855-8; Ochando J.C., Chen S.H. Myeloid-derived suppressor cells in transplantation and cancer. Immunol Res 2012;54(1-3):275-85. DOI:10.1007/s12026-012-8335-1; Gabitass R.F., Annels N.E., Stocken D.D. et al. Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol 2011;60(10):1419-30. DOI:10.1007/s00262-011-1028-0; Qian B.Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010;141(1):39-51. DOI:10.1016/j.cell.2010.03.014; Mantovani A., Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 2010;22(2):231-7. DOI:10.1016/j.coi.2010.01.009; Liu C.Y., Wang Y.M., Wang C.L. et al. Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14(-)/CD15+/CD33+ myeloid-derived suppressor cells and CD8 + T lymphocytes in patients with advanced-stage non-small cell lung cancer. J Cancer Res Clin Oncol 2010;136(1):35-45. DOI:10.1007/s00432-009-0634-0; Kusmartsev S., Nefedova Y., Yoder D., Gabrilovich D.I. Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J Immunol 2004;172(2):989-99. DOI:10.4049/jimmunol.172.2.989; Cheng P., Corzo C.A., Luetteke N. et al. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med 2008;205(10):2235-49. DOI:10.1084/jem.20080132; Brandau S., Trellakis S., Bruderek K. et al. Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J Leukoc Biol 2011;89(2):311-7. DOI:10.1189/jlb.0310162; Gallina G., Dolcetti L., Serafini P. et al. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J Clin Invest 2006;116(10):2777-90. DOI:10.1172/jci28828; Bronte V., Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 2005;5(8):641-54. DOI:10.1038/nri1668; Vasquez-Dunddel D., Pan F., Zeng Q. et al. STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients. J Clin Invest 2013;123(4):1580-9. DOI:10.1172/jci60083; Guilliams M., Bruhns P., Saeys Y. et al. The function of Ғсү receptors in dendritic cells and macrophages. Nat Rev Immunol 2014;14:94-108. DOI:10.1038/nri3582; Jing L., Srivastava R.V., Ettyreddy A. et al. Cetuximab ameliorates suppressive phenotypes of myeloid antigen presenting cells in head and neck cancer patients. J Immunother Cancer 2015;3:54. DOI:10.1186/s40425-015-0097-6; Стукань А.И., Мурашко Р.А., Цыган Н.А. и др. Адаптивный иммунный ответ в патогенезе и лечении плоскоклеточного рака головы и шеи: влияние факторов иммуносупрессии и гендерных особенностей. Опухоли головы и шеи 2022;12(3):114-26. (In Russ.). DOI:10.17650/2222-1468-2022-12-3-114-126; Кутукова С.И., Беляк Н.П., Раскин Г.А. и др. Системное воспаление и иммунологическое микроокружение в прогнозе течения солидных опухолей. Злокачественные опухоли 2019;9(1):29-37.; Zimmermann M., Zouhair A., Azria D. et al. The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications. Radiat Oncol 2006;1:11. DOI:10.1186/1748-717x-1-11; Ray K., Ujvari B., Ramana V. et al. Cross-talk between EGFR and IL-6 drives oncogenic signaling and offers therapeutic opportunities in cancer. Cytokine Growth Factor Rev 2018;41:18-27. DOI:10.1016/j.cytogfr.2018.04.002; Grellier N., Deray G., Yousfi A. et al. Carence martiale fonctionnelle, inflammation et fatigue apres radiotherapie Functional iron deficiency, inflammation and fatigue after radiotherapy. Bull Cancer 2015;102(9):780-5. DOI: 10. 1016/j.bulcan.2015.06.001; Bonner J.A., Harari P.M., Giralt J. et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;354(6):567-78. DOI:10.1056/nejmoa053422; Ang K.K., Zhang Q., Rosenthal D.I. et al. Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J Clin Oncol 2014;32(27):2940-50. DOI: 1200/jco.2013.53.5633; Maahs L., Ghanem A.I., Gutta R. Cetuximab and anemia prevention in head and neck cancer patients undergoing radiotherapy BMC Cancer 2022;22:626. DOI:10.1186/s12885-022-09708-9; Horsman M.R., Soresen B.S., Busk M. et al. Therapeutic modification of hypoxia. Clini Oncol 2021;33(11):492-509. DOI:10.1016/j.clon.2021.08.014; https://ogsh.abvpress.ru/jour/article/view/965

Διαθεσιμότητα: https://ogsh.abvpress.ru/jour/article/view/965
https://doi.org/10.17650/2222-1468-2024-14-1-16-30

Markers of oncological prognosis in the surgical treatment of oral squamous cell carcinoma ; Маркеры онкологического прогноза при хирургическом лечении плоскоклеточного рака полости рта

Συγγραφείς: A. I. Stukan, D. E. Kulbakin, T. Y. Semiglazova, Ya. V. Shvaykovskaya, E. A. Nefedova, I. I. Aseeva, А. И. Стукань, Д. Е. Кульбакин, Т. Ю. Семиглазова, Я. В. Швейковская, Е. А. Нефедова, И. И. Асеева

Συνεισφορές: The work was performed without external funding, Работа выполнена без спонсорской поддержки

Πηγή: Head and Neck Tumors (HNT); Том 13, № 4 (2023); 58-64 ; Опухоли головы и шеи; Том 13, № 4 (2023); 58-64 ; 2411-4634 ; 2222-1468 ; 10.17650/2222-1468-2023-13-4

Θεματικοί όροι: трансплантат, postoperative complications, systemic inflammatory response, modulation of inflammation, graft, послеоперационные осложнения, системная воспалительная реакция, управление воспалительной реакцией

Περιγραφή αρχείου: application/pdf

Relation: https://ogsh.abvpress.ru/jour/article/view/937/607; Cho S.K., Mattke S., Gordon H. et al. Development of a model to predict healing of chronic wounds within 12 weeks. Adv Wound Care (New Rochelle) 2020;9(9):516–24. DOI:10.1089/wound.2019.1091; Chen L., Arbieva Z.H., Guo S. et al. Positional differences in the wound transcriptome of skin and oral mucosa. BMC Genomics 2010;11:471. DOI:10.1186/1471-2164-11-471; Turabelidze A., Guo S., Chunget Y.A. et al. Intrinsic differences between oral and skin keratinocytes. PLOS One 2014;9(9):e101480. DOI:10.1371/journal.pone.0101480; Toma A.I., Fuller J.M., Willettet N.J. et al. Oral wound healing models and emerging regenerative therapies. Transl Res 2021;236:17–34. DOI:10.1016/j.trsl.2021.06.003; Politis P., Schoenaers J., Jacobs R. et al. Wound healing problems in the mouth. Front Physiol 2016;7:507. DOI:10.3389/fphys.2016.00507; Funato N., Moriyama K., Baba Y. et al. Evidence for apoptosis induction in myofibroblasts during palatal mucoperiosteal repair. J Dent Res 1999;78(9):1511–7. DOI:10.1177/00220345990780090501; Eming S.A., Hammerschmidt M., Krieg T. et al. Interrelation of immunity and tissue repair or regeneration. Semin Cell Dev Biol 2009;20:517–27. DOI:10.1016/j.semcdb.2009.04.009; Des Jardins-Park H., Mascharak Sh., Chinta M.S. et al. The spectrum of scarring in craniofacial wound repair. Front Physiol 2019;10:322. DOI:10.3389/fphys.2019.00322; Boscolo-Rizzo P., D’Alessandro A., Polesel J. et al. Different infammatory blood markers correlate with specific outcomes in incident HPV-negative head and neck squamous cell carcinoma : a retrospective cohort study. BMC Cancer 2022;22(1):243. DOI:10.1186/s12885-022-09327-4; Velnar T., Bailey T., Smrkolj V. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res 2009;37(5):1528–42. DOI:10.1177/147323000903700531; Schultz G.S., Wysocki A. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen 2009;17(2):153–62. DOI:10.1111/j.1524-475X.2009.00466.x; Lobmann R., Schultz G., Lehnert H. Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes Care 2005;28(2):461–71. DOI:10.2337/diacare.28.2.461; Yamagata K., Fukuzawa S., Ishibashi-Kanno N. et al. Association between the C-reactive protein/albumin ratio and prognosis in patients with oral squamous cell carcinoma. Scientific Rep 2021;11(1):5446. DOI:10.1038/s41598-021-83362-2; Gabrilovich D.G., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009;9(3):162–74. DOI:10.1038/nri2506; Li D., Wang Ch., Wei W. et al. Postoperative complications of free flap reconstruction in moderate-advanced head and neck squamous cell carcinoma: a prospective cohort study based on real-world data. Front Oncol 2022;12:792462. DOI:10.3389/fonc.2022.792462; Lin P.C., Kuo P.J., Kuo S.Ch. et al. Risk factors associated with postoperative complications of free anterolateral thigh flap placement in patients with head and neck cancer: analysis of propensity score-matched cohorts. Microsurgery 2020;40(5):538–44. DOI:10.1002/micr.30587; Spanier G., Böttcher J., Gerken M. et al. Prognostic. Value of perioperative red blood cell transfusion and anemia on survival and recurrence in oral squamous cell carcinoma. Oral Oncol 2020;107:104773. DOI:10.1016/j.oraloncology.2020.104773; Giannoudis P.V., Smith M.R., Evans R.T. et al. Serum CRP and IL-6 levels after trauma: not predictive of septic complications in 31 patients. Acta Orthop Scand 1998;69(2):184–8. DOI:10.3109/17453679809117625; Khandavilli S.D., Ceallaigh P.O., Lloyd C.J. et al. Serum C-reactive protein as a prognostic indicator in patients with oral squamous cell carcinoma. Oral Oncol 2009;45(10):912–4. DOI:10.1016/j.oraloncology.2009.03.015; Kruse A.L., Luebbers H.T., Gratz K.W. C-reactive protein levels: a prognostic marker for patients with head and neck cancer? Head Neck Oncol 2010;2:21. DOI:10.1186/1758-3284-2-21; Lee S., Kim D.W., Kwon S. Prognostic value of systemic inflammatory markers for oral cancer patients based on the 8 th edition of AJCC staging system. Sci Rep 2020;10(1):12111. DOI:10.1038/s41598-020-68991-3; Diao P., Wu Y., Li J. et al. Preoperative systemic immune-inflammation index predicts prognosis of patients with oral squamous cell carcinoma after curative resection. J Transl Med 2018;16:365. DOI:10.1186/s12967-018-1742-x; Kao S.C., Pavlakis N., Harvie R. et al. High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res 2010;16(23):5805–13. DOI:10.1158/1078-0432.CCR-10-2245; Ong H.S., Gokavarapu S., Wang L.Z. et al. Low pretreatment lymphocyte-monocyte ratio and high platelet-lymphocyte ratio indicate poor cancer outcome in early tongue cancer. J Oral Maxillofac Surg 2017;75(8):1762–74. DOI:10.1016/j.joms.2016.12.023; Mattavelli D., Lombardi D., Missale F. et al. Prognostic nomograms in oral squamous cell carcinoma: The negative impact of low neutrophil to lymphocyte ratio. Front Oncol 2019;9:339. DOI:10.3389/fonc.2019.00339; Liu X., Sun X., Liu J. et al. Preoperative C-reactive protein/albumin ratio predicts prognosis of patients afer curative resection for gastric cancer. Transl Oncol 2015;8(4):339–45. DOI:10.1016/j.tranon.2015.06.006; Кутукова С.И., Беляк Н.П., Иваськова Ю.В. Прогностическая роль факторов системного воспаления в течении плоскоклеточного рака слизистой оболочки полости рта. Медицинский алфавит 2021;10:28–34. DOI:10.33667/2078-5631-2021-10-28-34; Кутукова С.И., Беляк Н.П., Иваськова Ю.В. Системное воспаление в течении аденогенного рака слюнных желез. Ученые записки Первого Санкт-Петербургского государственного медицинского университета имени академика И.П. Павлова 2022;29(3):74–80. DOI:10.24884/1607-4181-2022-29-3-74-80; Kudou K., Saeki H., Nakashima Y. et al. C-reactive protein/albuminratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer. J Gastroenterol Hepatol 2019;34(2): 355–63. DOI:10.1111/jgh.14442; Crumley A.B.C., Stuart R.C., McKernan M. et al. Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer? World J Surg 2010;34(10):2393–8. DOI:10.1007/s00268-010-0641-y; Takebe J., Champagne C.M., Offenbacher Ishibashi S.K. et al. Titanium surface topography alters cell shape and modulates bone morphogenetic protein 2 expression in the J774A.1 macrophage cell line. J Biomed Mater Res Part A 2003;64(2):207–16. DOI:10.1002/jbm.a.10275; Laschke M.W., Harder Y., Amon M. et al. Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng 2006;12(8):2093–104. DOI:10.1089/ten.2006.12.2093; Kuboki Y., Jin Q., Kikuchi M. et al. Geometry of artificial ECM: sizes of pores controlling phenotype expression in BMP-induced osteogenesis and chondrogenesis. Connect Tissue Res 2002; 43(2–3):529–34. DOI:10.1080/03008200290001104; Wu G., Liu Y., Iizuka T. et al. The effect of a slow mode of BMP-2 delivery on the inflammatory response provoked by bone-defect-filling polymeric scaffolds. Biomaterials 2010;31(29):7485–93. DOI:10.1016/j.biomaterials.2010.06.037; Suarato G., Bertorelli R., Athanassiou A. Borrowing from nature: biopolymers and biocomposites as smart wound care materials. Front Bioeng Biotechnol 2018;6:137. DOI:10.3389/fbioe.2018.00137; Refai A.K., Textor M., Brunette D.M. et al. Effect of titanium surface topography on macrophage activation and secretion of proinflammatory cytokines and chemokines. J Biomed Mater Res A 2004;70(2):194–205. DOI:10.1002/jbm.a.30075; Mendonça G., Mendonça D.B., Aragão F.J. et al. Advancing dental implant surface technology – from micron- to nanotopography. Biomaterials 2008;29(28):3822–35. DOI:10.1016/j.biomaterials.2008.05.012; Ma Q.L., Zhao L.Z., Liu R.R. et al. Improved implant osseointegration of a nanostructured titanium surface via mediation of macrophage polarization. Biomaterials 2014;35(37):9853–67. DOI:10.1016/j.biomaterials.2014.08.025; Paul N.E., Skazik C., Harwardt M. et al. Topographical control of human macrophages by a regularly microstructured polyvinylidene fluoride surface. Biomaterials 2008;29(30):4056–64. DOI:10.1016/j.biomaterials.2008.07.010; Jones J.A., Chang D.T., Meyerson H. et al. Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells. Biomed Mater Res Part A 2007;83(3):585–96. DOI:10.1002/jbm.a.31221; Yun J.K., DeFife K., Colton E. et al. Human monocyte/macrophage adhesion and cytokine production on surface-modified poly(tetrafluoroethylene/hexafluoropropylene) polymers with and without protein preadsorption. J Biomed Mater Res 1995;29(2):257–68. DOI:10.1002/jbm.820290217; Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008;8:958–69. DOI:10.1038/nri2448; Arnold L., Henry A., Poron F. et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 2007;204(5): 1057–69. URL: https://www.researchgate.net/publication/6344940_Inflammatory_monocytes_recruited_after_skeletal_muscle_injury_switch_into_antiinflammatory_macrophages_to_support_myogenesis; Kim S.G. Immunomodulation for maxillofacial reconstructive surgery Kim Maxillofac Plast Reconstr Surg 2020;42(1):5. DOI:10.1186/s40902-020-00249-4; https://ogsh.abvpress.ru/jour/article/view/937

Διαθεσιμότητα: https://ogsh.abvpress.ru/jour/article/view/937
https://doi.org/10.17650/2222-1468-2023-13-4-58-64

Патогенетические аспекты коморбидности хронического панкреатита и хронической обструктивной болезни легких

Συγγραφείς: Hristich, T.N., Hontsariuk, D.O.

Πηγή: GASTROENTEROLOGY; Том 53, № 1 (2019); 54-61
Гастроэнтерология-Gastroenterologìa; Том 53, № 1 (2019); 54-61
Гастроентерологія-Gastroenterologìa; Том 53, № 1 (2019); 54-61

Θεματικοί όροι: 03 medical and health sciences, chronic pancreatitis, chronic obstructive pulmonary disease, syntropy, transsyndromicity, chronic systemic inflammatory response, hypoxia, review, 0302 clinical medicine, хронический панкреатит, хроническая обструктивная болезнь легких, синтропия, транссиндромность, хроническая системная воспалительная реакция, гипоксия, обзор, хронічний панкреатит, хронічне обструктивне захворювання легень, синтропія, транссиндромальність, хронічна системна запальна реакція, гіпоксія, огляд, 3. Good health

Περιγραφή αρχείου: application/pdf

Σύνδεσμος πρόσβασης: http://gastro.zaslavsky.com.ua/article/download/163459/165317
http://gastro.zaslavsky.com.ua/article/view/163459

Pathogenetic Mechanisms of Organ Dysfunction in Severe Concomitant Trauma ; Патогенетические механизмы органной дисфункции при тяжелой сочетанной травме

Συγγραφείς: G. V. Bulava, Г. В. Булава

Πηγή: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 12, № 1 (2023); 92-98 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 12, № 1 (2023); 92-98 ; 2541-8017 ; 2223-9022

Θεματικοί όροι: микробиом, acute blood loss, systemic inflammatory reaction, cytokines, traumatic brain injury, microbiome, острая кровопотеря, системная воспалительная реакция, цитокины, черепно-мозговая травма

Περιγραφή αρχείου: application/pdf

Relation: https://www.jnmp.ru/jour/article/view/1574/1278; https://www.jnmp.ru/jour/article/view/1574/1299; World Health Organization. Global Health Estimates: Life expectancy and leading causes of death and disability. Deaths by cause, age and sex. Available at: http://www.who.int/healthinfo/global_burden_disease/estimates/en/ index1.html [Accessed 21 february 2023]; World Health Organization. Violence and injuries: the facts. Geneva, Switzerland: World Health Organization; 2010.; Lord JM, Midwinter MJ, Chen YF, Belli A, Brohi K, Kovacs EJ, et al. The systemic immune response to trauma: an overview of pathophysiology and treatment. Lancet. 2014;384(9952):1455–1465. PMID: 25390327 https://doi. org/10.1016/S0140-6736(14)60687-5; Sauaia A, Moore FA, Moore EE. Postinjury inflammation and organ dysfunction. Crit Care Clin. 2017;33(1):167–191. PMID: 27894496 https://doi. org/10.1016/j.ccc.2016.08.006; Gabbe BJ, Simpson PM, Cameron PA, Ponsford J, Lyons RA, Collie A, et al. Long-term health status and trajectories of seriously injured patients: a population-based longitudinal study. PLoS Med. 2017;14(7):e1002322. PMID: 28678814 https://doi.org/10.1371/journal.pmed.1002322 eCollection 2017 Jul.; Callcut RA, Wakam G, Conroy AS, Kornblith LZ, Howard BM, Campion EM, et al. Discovering the truth about life after discharge: Long-term traumarelated mortality. J Trauma Acute Care Surg. 2016;80(2):210–217. PMID: 26606176 https://doi.org/10.1097/TA.0000000000000930; Tonglet ML, Greiffenstein P, Pitance F, Degesves S. Massive bleeding following severe blunt trauma: the first minutes that can change everything. Acta Chir Belg. 2016;116(1):11–15. PMID: 27385134 https://doi.org/10.1080/ 00015458.2015.1136488; Vargas M, García A, Caicedo Y, Parra MW, Ordoñez CA. Vargas M, et al. Damage control in the intensive care unit: what should the intensive care physician know and do? Colomb Med (Cali). 2021;52(2):e4174810. PMID: 34908625 https://doi.org/10.25100/cm.v52i2.4810; Tien HC, Spencer F, Tremblay LN, Rizoli SB, Brenneman FD. Preventable deaths from hemorrhage at a level I Canadian trauma center. J Trauma. 2007;62(1):142–146. PMID: 17215745 https://doi.org/10.1097/01. ta.0000251558.38388.47; Schäfer N, Driessen A, Fröhlich M, Stürmer EK, Maegele M; TACTIC partners. Diversity in clinical management and protocols for the management of major bleeding of trauma patients across European level 1 Trauma Centres. Scand J Trauma Resusc Emerg Med. 2015;23:74. PMID: 26428070 https://doi. org/10.1186/s13049-015-0147-6; Chin-Yee IH, Gray-Statchuk L, Milkovich S, Ellis CG. Transfusion of stored red blood cells adhere in the rat microvasculature. Transfusion. 2009;49(11):2304– 2310. PMID: 19624601 https://doi.org/10.1111/j.1537-2995.2009.02315.x; D’Alessandro A, Liumbruno G, Grazzini G, Zolla L. Red blood cell storage: the story so far. Blood Transfusion. 2010;8(2):82–88. PMID: 20383300 https://doi. org/10.2450/2009.0122-09; Jy W, Ricci M, Shariatmadar S, Gomez-Marin O, Horstman LH, Ahn YS. Microparticles in stored red blood cells as potential mediators of transfusion complications. Transfusion. 2011;51(4):886–893. PMID: 21496051 https:// doi.org/10.1111/j.1537-2995.2011.03099.x; Curry N, Brohi K. Surgery in Traumatic Injury and Perioperative Considerations. Semin Thromb Hemost. 2020;46(1):73–82. PMID: 31563126 https://doi.org/10.1055/s-0039-1697932; Lenz A, Franklin GA, Cheadle WG. Systemic inflammation after trauma. Injury. 2007;38(12):1336–1345. PMID: 18048040 https://doi.org/10.1016/ j.injury.2007.10.003; Агаджанян В.В. (ред.) Политравма. Септические осложнения. Новосибирск: Наука; 2005.; Wafaisade AP, Lefering RMD, Bouillon BMD, Sakka SGMD, Thamm OCMD, Paffrath TMD, et al.; Trauma Registry of the German Society for Trauma Surgery. Epidemiology and risk factors of sepsis after multiple trauma: An analysis of 29,829 patients from the Trauma Registry of the German Society for Trauma Surgery. Crit Care Med. 2011;39(4):621–628. PMID: 21242798 https://doi.org/10.1097/CCM.0b013e318206d3df; Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464(7285):104–107. PMID: 20203610 https://doi.org/10.1038/ nature08780; Pugin J. How tissue injury alarms the immune system and causes a systemic inflammatory response syndrome. Ann Intensive Care. 2012;2(1):27. PMID: 22788849 https://doi.org/10.1186/2110-5820-2-27; Manson J, Thiemermann C, Brohi K. Trauma alarmins as activators of damage-induced inflammation. Brit J Surg. 2012;99(Suppl 1):12–20. PMID: 22441851 https://doi.org/0.1002/bjs.7717; Liew PX, Kubes P. The Neutrophil’s Role During Health and Disease. Physiol Rev. 2019;99(2):1223–1248. PMID: 30758246 https://doi.org/10.1152/ physrev.00012.2018; Rosales C. Neutrophils at the crossroads of innate and adaptive immunity. J Leukoc Biol. 2020;108(1):377–396. PMID: 32202340 https://doi.org/10.1002/ JLB.4MIR0220-574RR; Arango Duque G, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol. 2014;5:491. PMID: 25339958 https://doi.org/10.3389/fimmu.2014.00491 eCollection 2014.; Huber-Lang M, Lambris JD, Ward PA. Innate immune responses to trauma. Nat Immunol. 2018;19(4):327–341. PMID: 29507356 https://doi.org/10.1038/ s41590-018-0064-8; Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell. 2012;148(6):1145–1159. PMID: 22424226 https://doi.org/10.1016/ j.cell.2012.02.035; Galluzzi L, Kepp O, Trojel-Hansen C, Kroemer G. Mitochondrial control of cellular life, stress, and death. Circulation Research. 2012;111(9):1198–1207. PMID: 23065343 https://doi.org/10.1161/CIRCRESAHA.112.268946; West AP, Shadel GS. Mitochondrial DNA in innate immune responses and inflammatory pathology. Nat Revs Immunol. 2017;17(6):363–375. PMID: 28393922 https://doi.org/10.1038/nri.2017.21; Nakahira K, Hisata S, Choi AM. The Roles of Mitochondrial Damage-Associated Molecular Patterns in Diseases. Antioxid Redox Signal. 2015;23(17):1329– 1350. PMID: 26067258 https://doi.org/10.1089/ars.2015.6407; Boyapati RK, Rossi AG, Satsangi J, Ho GT. Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications. Mucosal Immunol. 2016;9(3):567– 582. PMID: 26931062 https://doi.org/10.1038/mi.2016.14; Krychtiuk KA, Ruhittel S, Hohensinner PJ, Koller L, Kaun C, Lenz M, et al. Mitochondrial DNA and Toll-Like Receptor-9 Are Associated with Mortality in Critically Ill Patients. Crit Care Med. 2015;43(12):2633–2641. PMID: 26448617 https://doi.org/10.1097/CCM.0000000000001311; Nakahira K, Kyung SY, Rogers AJ, Gazourian L, Youn S, Massaro AF, et al. Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation. PLoS Med. 2013;10(12):e1001577. PMID: 24391478 https://doi.org/10.1371/journal.pmed.1001577; Хубутия М.Ш., Шабанов А.К., Скулачев М.В., Булава Г.В., Савченко И. М., Гребенников О.А., и др. Митохондриальная и ядерная ДНК у пострадавших с тяжелой сочетанной травмой. Общая реаниматология. 2013;9(6):24–35.; Gołąbek-Dropiewska K, Pawłowska J, Witkowski J, Lasek J, Marks W, Stasiak M, et al. Analysis of selected pro- and anti-inflammatory cytokines in patients with multiple injuries in the early period after trauma. Cent Eur J Immunol. 2018;43(1):42–49. PMID: 29731691 https://doi.org/10.5114/ceji.2018.74872; Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, et al. A genomic storm in critically injured humans. J Exp Med. 2011;208(13):2581– 2590. PMID: 22110166 https://doi.org/10.1084/jem.20111354; Hildebrand F, Pape HC, Krettek C. Die Bedeutung der Zytokine in der posttraumatischen Entzündungsreaktion [The importance of cytokines in the posttraumatic inflammatory reaction]. Unfallchirurg. 2005;108(10):793– 794, 796–803. PMID: 16175346 https://doi.org/10.1007/s00113-005-1005-1; Gentile LF, Cuenca AG, Efron PA, Ang D, Bihorac A, McKinley BA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg. 2012;72(6):1491–1501. PMID: 22695412 https://doi.org/0.1097/ TA.0b013e318256e000; Duggal NA, Upton J, Phillips AC, Sapey E, Lord JM. An age-related numerical and functional deficit in CD19(+) CD24(hi) CD38(hi) B cells is associated with an increase in systemic autoimmunity. Aging Cell. 2013;12(5):873–881. PMID: 23755918 https://doi.org/10.1111/acel.12114; Bruijns SR, Guly HR, Bouamra O, Lecky F, Lee WA. The value of traditional vital signs, shock index, and age-based markers in predicting trauma mortality. J Trauma Acute Care Surg. 2013;74(6):1432–1437. PMID: 23694869 https://doi.org/10.1097/TA.0b013e31829246c7; Burk AM, Martin M, Flierl MA, Rittirsch D, Helm M, Lampl L, et al. Early complementopathy after multiple injuries in humans. Shock. 2012;37(4):348– 354. PMID: 22258234 https://doi.org/10.1097/SHK.0b013e3182471795; Jenne CN, Urrutia R, Kubes P. Platelets: bridging hemostasis, inflammation, and immunity. Int J Lab Hematol. 2013;35(3):254–261. PMID: 23590652 https://doi.org/10.1111/ijlh.12084; van Gils JM, Zwaginga JJ, Hordijk PL. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leukoc Biol. 2009;85(2):195–204. PMID: 18948548 https://doi.org/10.1189/jlb.0708400; Laffont B, Corduan A, Ple H, Duchez AC, Cloutier N, Boilard E, et al. Activated platelets can deliver mRNA regulatory Ago2 microRNA complexes to endothelial cells via microparticles. Blood. 2013;122(2):253–261. PMID: 23652806 https://doi.org/10.1182/blood-2013-03-492801; Timar CI, Lorincz AM, Csepanyi-Komi R, Valyi-Nagy A, Nagy G, Buzas EI, et al. Antibacterial effect of microvesicles released from human neutrophilic granulocytes. Blood. 2013;121(3):510–518. PMID: 23144171 https://doi. org/10.1182/blood-2012-05-431114; Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol. 2009;19(2):43–51. PMID: 19144520 https://doi. org/10.1016/j.tcb.2008.11.003; Leonard JM, Zhang CX, Lu L, Hoofnagle MH, Fuchs A, Clemens RA, et al. Extrathoracic multiple trauma dysregulates neutrophil function and exacerbates pneumonia-induced lung injury. J Trauma Acute Care Surg. 2021;90(6):924–934. PMID: 34016916 https://doi.org/10.1097/ TA.0000000000003147; Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532– 1535. PMID: 15001782 https://doi.org/10.1126/science.1092385; Hietbrink F, Koenderman L, Althuizen M, Leenen LP. Modulation of the innate immune response after trauma visualised by a change in functional PMN phenotype. Injury. 2009;40(8):851–855. PMID: 19339006 https://doi. org/10.1016/j.injury.2008.11.002; Groeneveld KM, Koenderman L, Warren BL, Jol S, Leenen LPH, Hietbrink F. Early decreased neutrophil responsiveness is related to late onset sepsis in multitrauma patients: An international cohort study. PLoS One. 2017;12(6): e0180145. PMID: 28665985 https://doi.org/10.1371/journal.pone.0180145 eCollection 2017.; Serhan CN, Chiang N. Resolution phase lipid mediators of inflammation: agonists of resolution. Curr Opin Pharmacol. 2013;13(4):632–640. PMID: 23747022 https://doi.org/ 10.1016/j.coph.2013.05.012; McKee CA, Lukens JR. Emerging roles for the immune system in traumatic brain injury. Front Immunol. 2016;7:556. PMID: 27994591 https://doi. org/10.3389/fimmu.2016.00556 eCollection 2016.; Liu MH, Tian J, Su YP, Wang T, Xiang Q, Wen L. Cervical sympathetic block regulates early systemic inflammatory response in severe trauma patients. Med Sci Monitor. 2013;19:194–201. PMID: 23492458 https://doi. org/10.12659/MSM.883833; Hall S, Kumaria A, Belli A. The role of vagus nerve overactivity in the increased incidence of pneumonia following traumatic brain injury. Br J Neurosurg. 2014;28(2):181–186. PMID: 24024980 https://doi.org/10.3109/02 688697.2013.835373; Bellander BM, Singhrao SK, Ohlsson M, Mattsson P, Svensson M. Complement activation in the human brain after traumatic head injury. J Neurotrauma. 2001;18(12):1295–1311. PMID: 11780861 https://doi.org/10.1089/08977150 152725605; Braun M, Vaibhav K, Saad NM, Fatima S, Vender JR, Baban B, et al. White matter damage after traumatic brain injury: A role for damage associated molecular patterns. Biochim Biophys Acta Mol Basis Dis. 2017; 1863(10 Pt B):2614–2626. PMID: 28533056 https://doi.org/10.1016/j.bbadis.2017.05.020; Kharrazian D. Traumatic Brain Injury and the Effect on the Brain-Gut Axis. Altern Ther Health Med. 2015;21(Suppl 3):28–32. PMID: 26348611; Patterson TT, Nicholson S, Wallace D, Hawryluk GWJ, Grandhi R. Complex Feed-Forward and Feedback Mechanisms Underlie the Relationship Between Traumatic Brain Injury and the Gut-Microbiota-Brain Axis. Shock. 2019;52(3):318–325. PMID: 30335675 https://doi.org/10.1097/ SHK.0000000000001278; Sundman MH, Chen NK, Subbian V, Chou YH. The bidirectional gut-brain-microbiota axis as a potential nexus between traumatic brain injury, inflammation, and disease. Brain Behav Immun. 2017;66:31–44. PMID: 28526435 https://doi.org/10.1016/j.bbi.2017.05.009; Alverdy JC. Microbiome Medicine: This Changes Everything. J Am Coll Surg. 2018;226(5):719–729. PMID: 29505823 https://doi.org/10.1016/j.jamcollsurg .2018.02.004; Patel JJ, Rosenthal MD, Miller KR, Martindale RG. The gut in trauma. Curr Opin Crit Care. 2016;22(4):339–346. PMID: 27314259 https://doi. org/10.1097/MCC.0000000000000331; Hang CH, Shi JX, Li JS, Li WQ, Yin HX. Up-regulation of intestinal nuclear factor kappa B and intercellular adhesion molecule-1 following traumatic brain injury in rats. World J Gastroenterol. 2005;11(8):1149–1154. PMID: 15754395 https://doi.org/10.3748/wjg.v11.i8.1149; Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9(5):313–323. PMID: 19343057 https://doi.org/10.1038/nri2515; Howard BM, Kornblith LZ, Christie SA, Conroy AS, Nelson MF, Campion EM, et al. Characterizing the gut microbiome in trauma: significant changes in microbial diversity occur early after severe injury. Trauma Surg Acute Care Open. 2017;2(1):e000108. PMID: 29766103 https://doi.org/10.1136/tsaco-2017-000108 eCollection 2017.; Shimizu K, Ojima M, Ogura H. Gut Microbiota and Probiotics/Synbiotics for Modulation of Immunity in Critically Ill Patients. Nutrients. 2021;13(7):2439. PMID: 34371948 https://doi.org/10.3390/nu13072439; Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015;28(2):203–209. PMID: 25830558; Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004;118(2):229–241. PMID: 15260992 https:// doi.org/10.1016/j.cell.2004.07.002; Ivanov II, Honda K Intestinal commensal microbes as immune modulators. Cell Host Microbe. 2012;12(4):496–508. PMID: 23084918 https://doi. org/10.1016/j.chom.2012.09.009; Burmeister DM, Johnson TR, Lai Z, Scroggins SR, DeRosa M, Jonas RB, et al. The gut microbiome distinguishes mortality in trauma patients upon admission to the emergency department. J Trauma Acute Care Surg. 2020;88(5):579–587. PMID: 32039976 https://doi.org/10.1097/TA.0000000000002612; Nielson JL, Paquette J, Liu AW, Guandique CF, Tovar CA, Inoue T, et al. Topological data analysis for discovery in preclinical spinal cord injury and traumatic brain injury. Nat Commun. 2015;6:8581. PMID: 26466022 https:// doi.org/10.1038/ncomms9581; https://www.jnmp.ru/jour/article/view/1574

Διαθεσιμότητα: https://www.jnmp.ru/jour/article/view/1574
https://doi.org/10.23934/2223-9022-2023-12-1-92-98

Systemic Inflammatory Response as a Prognostic Factor in Breast Cancer. Part II. Hematological Markers of Inflammation ; Системная воспалительная реакция как фактор прогноза при раке молочной железы. Часть II. Гематологические маркеры воспаления

Συγγραφείς: Sergeeva N.S., Karmakova T.A., Polyak M.A., Alentov I.I.

Συνεισφορές: 1

Πηγή: Annals of the Russian academy of medical sciences; Vol 77, No 6 (2022); 408-419 ; Вестник Российской академии медицинских наук; Vol 77, No 6 (2022); 408-419 ; 2414-3545 ; 0869-6047 ; 10.15690/vramn.776

Θεματικοί όροι: breast cancer, systemic inflammatory response, hematological markers, prognosis, рак молочной железы, системная воспалительная реакция, гематологические индексы, прогноз

Περιγραφή αρχείου: application/pdf

Relation: https://vestnikramn.spr-journal.ru/jour/article/view/2235/1720; https://vestnikramn.spr-journal.ru/jour/article/view/2235/1733; https://vestnikramn.spr-journal.ru/jour/article/view/2235/1746; https://vestnikramn.spr-journal.ru/jour/article/view/2235/1751; https://vestnikramn.spr-journal.ru/jour/article/downloadSuppFile/2235/2632

Διαθεσιμότητα: https://vestnikramn.spr-journal.ru/jour/article/view/2235
https://doi.org/10.15690/vramn2235

HISTOMORPHOLOGICAL CHARACTERIS- TICS OF SYSTEMIC INFLAMMATORY RESPONSE REACTION AND ABDOMINALSEPSIS DEVELOPMENT

Συγγραφείς: Карлійчук, O., Іващук, O., Хомко, O.

Πηγή: Clinical anatomy and operative surgery; Vol. 3 No. 1 (2004); 32-39
Клиническая анатомия и оперативная хирургия; Том 3 № 1 (2004); 32-39
Клінічна анатомія та оперативна хірургія; Том 3 № 1 (2004); 32-39

Θεματικοί όροι: абдомінальний сепсис, системна запальна реакція, патоморфоз, абдоминальный сепсис, системная воспалительная реакция, abdominal sepsis, systemic inflammatory reaction, pathomorphosis, 3. Good health

Περιγραφή αρχείου: application/pdf

Σύνδεσμος πρόσβασης: http://kaos.bsmu.edu.ua/article/view/264717

The level of microRNA expression in cardiac surgery patients depends on postoperative multiorgan failure ; Уровень экспрессии микроРНК у кардиохирургических пациентов зависит от наличия полиорганной недостаточности в послеоперационном периоде

Συγγραφείς: Grigoryev E.V., Ponasenko A.V., Tsepokina A.V., Ivkin A.A., Kornelyuk R.A.

Συνεισφορές: 0

Πηγή: Almanac of Clinical Medicine; Vol 50, No 4 (2022); 217-225 ; Альманах клинической медицины; Vol 50, No 4 (2022); 217-225 ; 2587-9294 ; 2072-0505

Θεματικοί όροι: cardiac surgery, systemic inflammatory response, microRNA, multiple organ failure, кардиохирургия, системная воспалительная реакция, микроРНК, полиорганная недостаточность

Περιγραφή αρχείου: application/pdf

Relation: https://almclinmed.ru/jour/article/view/1732/1487; https://almclinmed.ru/jour/article/view/1732/1503; https://almclinmed.ru/jour/article/view/1732

Διαθεσιμότητα: https://almclinmed.ru/jour/article/view/1732
https://doi.org/10.18786/2072-0505-2022-50-036

MECHANISMS FOR THE FORMATION OF THE SECONDARY IMMUNOLOGICAL FAILURE IN SEVERE CRANIOCEREBRAL INJURY

Συγγραφείς: Тамара Ивановна Борщикова, Наталья Николаевна Епифанцева, Сергей Людовикович Кан, Максим Владимирович Додонов, Сергей Николаевич Филимонов

Πηγή: Медицина в Кузбассе, Vol 17, Iss 3, Pp 58-65 (2018)

Θεματικοί όροι: тяжелая черепно-мозговая травма, системная воспалительная реакция, иммуносупрессия, цитокины, апоптоз, Medicine

Περιγραφή αρχείου: electronic resource

Relation: http://mednauki.ru/index.php/MK/article/view/247; https://doaj.org/toc/1819-0901

Σύνδεσμος πρόσβασης: https://doaj.org/article/2875afcc3cca48a0ae6c9135e244efd7

The impact of bacterial overgrowth syndrome and systemic inflammation on abdominal hemodynamics in liver cirrhosis

Συγγραφείς: R. V. Maslennikov, M. A. Tatarkina, M. V. Mayevskaya, Ch. S. Pavlov, M. S. Zharkova, V. T. Ivashkin

Πηγή: Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 27, Iss 4, Pp 52-61 (2018)

Θεματικοί όροι: цирроз печени, избыточный бактериальный рост, системная воспалительная реакция, бактериальная транслокация, портальный кровоток, мезентериальный кровоток, Diseases of the digestive system. Gastroenterology, RC799-869

Περιγραφή αρχείου: electronic resource

Relation: https://www.gastro-j.ru/jour/article/view/169; https://doaj.org/toc/1382-4376; https://doaj.org/toc/2658-6673

Σύνδεσμος πρόσβασης: https://doaj.org/article/2094c66ec37144a899154aedb5e9ab16

Induced immunosuppression in critical care: diagnostic opportunities in clinical practice ; Индуцированная иммуносупрессия в критических состояниях: диагностические возможности в клинической практике

Συγγραφείς: E. Grigoryev V., V. Matveeva G., D. Shukevich L., A. Radivilko S., E. Velikanova A., M. Khanova Yu., Е. Григорьев В., В. Матвеева Г., Д. Шукевич Л., А. Радивилко С., Е. Великанова А., М. Ханова Ю.

Συνεισφορές: Grant for government support to leading science schools of the Russian Federation (contest NSH-2018, NSH 2696.2018.7), Грант для государственной поддержки ведущих научных школ Российской Федерации (Конкурс НШ-2018, НШ 2696.2018.7)

Πηγή: Bulletin of Siberian Medicine; Том 18, № 1 (2019); 18-29 ; Бюллетень сибирской медицины; Том 18, № 1 (2019); 18-29 ; 1819-3684 ; 1682-0363 ; 10.20538/1682-0363-2019-18-1

Θεματικοί όροι: systemic inflammatory reaction, persistent multi-organ failure, induced immunosup-pression, системная воспалительная реакция, персистирующая полиорганная недостаточность, индуцированная иммуносупрессия

Περιγραφή αρχείου: application/pdf

Relation: https://bulletin.tomsk.ru/jour/article/view/2167/1534; Medzhitov R., Schneider D.S., Soares M.P. Disease tolerance as a defense strategy. Science. 2012; 335: 936–941. DOI:10.1126/science.1214935.; Hotchkiss R.S., Monneret G., Payen D. Immunosuppression in sepsis: A novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013; 13 (3): 260–268. DOI:10.1016/S1473-3099(13)70001-X.; Schefold J.C., Hasper D., Reinke P., Monneret G., Volk H.D. Consider delayed immunosuppression into the concept of sepsis. Crit Care Med. 2008; 36 (11): 3118. DOI:10.1097/CCM.0b013e31818bdd8f.; Ward N.S., Casserly B., Ayala A. The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin. Chest Med. 2008; 29 (4): 617–625. DOI:10.1016/j.ccm.2008.06.010.; Monneret G., Venet F., Kullberg B.J., Netea M.G. ICU-acquired immunosuppression and the risk for secondary fungal infections. Med. Mycol. 2011; 49 (Suppl. 1): S17–S23. DOI:10.3109/13693786.2010.509744.; Hotchkiss R.S., Monneret G., Payen D. Sepsis-induced immunosuppression: From cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 2013; 13 (12): 862–874. DOI:10.1038/nri3552.; Delano M.J., Thayer T., Gabrilovich S., Kelly-Scumpia K.M., Winfield R.D., Scumpia P.O., Cuenca A.G., Warner E., Wallet S.M., Wallet M.A., O’Malley K.A., Ramphal R., Clare-Salzer M., Efron P.A., Mathews C.E., Moldawer L.L. Sepsis induces early alterations in innate immunity that impact mortality to secondary infection. J. Immunol. 2011; 186 (1): 195–202. DOI:10.4049/jimmunol.1002104.; Stephan F., Yang K., Tankovic J., Soussy C.J., Dhonneur G., Duvaldestin P., Brochard L., Brun-Buisson C., Harf A., Delclaux C. Impairment of polymorphonuclear neutrophil functions precedes nosocomial infections in critically ill patients. Crit. Care Med. 2002; 30 (2): 315–322.; Marini O., Costa S., Bevilacqua D., Calzetti F., Tamassia N., Spina C., De Sabata D., Tinazzi E., Lunardi C., Scupoli M.T., Cavallini C., Zoratti E., Tinazzi I., Marchetta A., Vassanelli A., Cantini M., Gandini G., Ruzzenente A., Guglielmi A., Missale F., Vermi W., Tecchio C., Cassatella M.A., Scapini P. Mature CD10+ and immature CD10- neutrophils present in G-CSF-treated donors display opposite effects on T cells. Blood. 2017; 129 (10): 1343–1356. DOI:10.1182/blood-2016-04-713206.; Orr Y., Taylor J.M., Bannon P.G., Geczy C., Kritharides L. Circulating CD10-/CD16 low neutrophils provide a quantitative index of active bone marrow neutrophil release. Br. J. Haematol. 2005; 131 (4): 508–519. DOI:10.1111/j.1365-2141.2005.05794.x.; Parihar A., Eubank T.D., Doseff A.I. Monocytes and macrophages regulate immunity through dynamic networks of survival and cell death. J. Innate. Immun. 2010; 2 (3): 204–215. DOI:10.1159/000296507.; Biswas S.K., Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 2009; 30 (10): 475–487. DOI:10.1016/j.it.2009.07.009.; Fumeaux T., Dufour J., Stern S., Pugin J. Immune monitoring of patients with septic shock by measurement of intraleukocyte cytokines. Intensive Care Med. 2004; 30 (11): 2028–2037. DOI:10.1007/s00134-004-2429-8.; Cavaillon J.M., Adrie C., Fitting C., Adib-Conquy M. Endotoxin tolerance: is there a clinical relevance? J. Endotoxin Research. 2003; 9 (2): 101–107. DOI:10.1179/096805103125001487.; Lukaszewicz A.C., Grienay M., Resche-Rigon M., Pirracchio R., Faivre V., Boval B., Payen D. Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit. Care Мed. 2009; 37 (10): 2746–2752. DOI:10.1097/CCM.; Delano M.J., Ward P.A. Sepsis-induced immune dysfunction: can immune therapies reduce mortality? J. Clin. Invest. 2016; 126 (1): 23–31. DOI:10.1172/JCI82224.; Pachot A., Cazalis M.A., Venet F., Turrel F., Faudot C., Voirin N., Diasparra J., Bourgoin N., Poitevin F., Mougin B., Lepape A., Monneret G. Decreased expression of the fractalkine receptor CX3CR1 on circulating monocytes as new feature of sepsis-induced immunosuppression. J. Immunol. 2008; 180 (9): 6421–6429. DOI:10.4049/jimmunol.180.9.6421.; Piani A., Hossle J.P., Birchler T., Siegrist C.A., Heumann D., Davies G., Loeliger S., Seger R., Lauener R.P. Expression of MHC class II molecules contributes to lipopolysaccharide responsiveness. Eur. J. Immunol. 2000; 30 (11): 3140–3146. DOI:10.1002/1521-4141(200011)30:113.0.CO;2-O.; Wolk K., Docke W.D., von Baehr V., Volk H.D., Sabat R. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood. 2000; 96 (1): 218–223.; Wolk K., Höflich C., Zuckermann-Becker H., Döcke W.D., Volk H.D., Sabat R. Reduced monocyte CD86 expression in postinflammatory immunodeficiency. Crit. Care Med. 2007; 35 (2): 458–467. DOI:10.1097/01.CCM.0000254724.54515.2F.; Venet F., Lukaszewicz A.C., Payen D., Hotchkiss R., Monneret G. Monitoring the immune response in sepsis: A rational approach to administration of immunoadjuvant therapies. Curr. Opin. Immunol. 2013; 25 (4): 477–483. DOI:10.1016/j.coi.2013.05.006.; Chenouard A., Braudeau C., Cottron N., Bourgoin P., Salabert N., Roquilly A., Josien R., Joram N., Asehnoune K. HLA-DR expression in neonates after cardiac surgery under cardiopulmonary bypass: a pilot study. Intensive Care Medicine Experimental. 2018; 6 (1): 1. DOI:10.1186/s40635-017-0166-x; Fabienne V., Cour M., Demaret J., Guillaume M., Laurent A. Decreased Monocyte HLA-DR Expression in Patients After Non-Shockable out-of-Hospital Cardiac Arrest. Shock. 2016; 46 (1): 33–36. DOI:10.1097/SHK.0000000000000561.; Umansky V., Sevko A. Tumor microenvironment and myeloid-derived suppressor cells. Cancer Microenviron. 2013; 6 (2): 169–177. DOI:10.1007/s12307-012-0126-7.; Bronte V., Brandau S., Chen S.-H., Colombo M.P., Frey A.B., Greten T.F., Mandruzzato S., Murray P.J., Ochoa A., Ostrand-Rosenberg S., Rodriguez P.C., Sica A., Umansky V., Vonderheide R.H., Gabrilovich D.I. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nature communications. 2016; 7: 12150. DOI:10.1038/ncomms12150.; Koehn B.H., Apostolova P., Haverkamp J.M., Miller J.S., McCullar V., Tolar J., Munn D.H., Murphy W.J., Brickey W.J., Serody J.S., Gabrilovich D.I., Bronte V., Murray P.J., Ting J.P., Zeiser R., Blazar B.R. GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells. Blood. 2015; 126 (13): 1621–1628. DOI:10.1182/blood-2015-03-634691.; Uhel F., Azzaoui I., Grégoire M., Pangault C., Dulong J., Tadiй J.M., Gacouin A., Camus C., Cynober L., Fest T., Le Tulzo Y., Roussel M., Tarte K. Early expansion of circulating granulocytic myeloid-derived suppressor cells predicts development of nosocomial infections in septic patients. Am. J. Respir. Crit. Care Med. 2017; 196 (3): 315–327. DOI:10.1164/rccm.201606-1143OC.; Gey A. Tadie J.M., Caumont-Prim A., Hauw-Berlemont C., Cynober L., Fagon J.Y., Terme M., Diehl J.L., Delclaux C., Tartour E. Granulocytic Myeloid-Derived Suppressor Cells inversely correlate with plasma arginine and overall survival in critically ill patients. Clin. Exp. Immunol. 2015; 180 (2): 280–288. DOI:10.1111/cei.12567.; Tadié J.M., Cynober L., Peigne V., Caumont-Prim A., Neveux N., Gey A., Guerot E., Diehl J.L., Fagon J.Y., Tartour E., Delclaux C. Arginine administration to critically ill patients with a low nitric oxide fraction in the airways: a pilot study. Intensive Care Med. 2013; 39 (9): 1663–1665. DOI:10.1007/s00134-013-2984-y.; Steinman R.M., Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 2006; 311: 17–58.; Riccardi F., Della Porta M.G., Rovati B., Casazza A., Radolovich D., De Amici M., Danova M., Langer M. Flow cytometric analysis of peripheral blood dendritic cells in patients with severe sepsis. Cytometry B Clin. Cytom. 2011; 80: 1421. DOI:10.1002/cyto.b.20540.; Guisset O., Dilhuydy M.S., Thiebaut R., Lefevre J., Camou F., Sarrat A., Gabinski C., Moreau J.F., Blanco P. Decrease in circulating dendritic cells predicts fatal outcome in septic shock. Intensive Care Med. 2007; 33 (1): 148–152. DOI:10.1007/s00134-006-0436-7.; Hotchkiss R.S., Tinsley K.W., Swanson P.E., Grayson M.H., Osborne D.F., Wagner T.H., Cobb J.P., Coopersmith C., Karl I.E. Depletion of dendritic cells, but not macrophages, in patients with sepsis. J. Immunol. 2002; 168 (5): 2493–2500. DOI:10.4049/jimmunol.168.5.2493.; Pastille E., Didovic S., Brauckmann D., Rani M., Agrawal H., Schade F.U., Zhang Y., Flohe S.B. Modulation of dendritic cell differentiation in the bone marrow mediates sustained immunosuppression after polymicrobial sepsis. J. Immunol. 2011; 186 (2): 977986. DOI:10.4049/jimmunol.1001147; Adrie C., Lugosi M., Sonneville R., Souweine B., Ruckly S., Cartier J.C., Garrouste-Orgeas M., Schwebel C., Timsit J.F. OUTCOMEREA study group. Persistent lymphopenia is a risk factor for ICU-acquired infections and for death in ICU patients with sustained hypotension at admission. Annals of Intensive Care. 2017; 7: 30. DOI:10.1186/s13613-017-0242-0.; Inoue S., Suzuki-Utsunomiya K., Okada Y., Taira T., Iida Y., Miura N., Tsuji T., Yamagiwa T., Morita S., Chiba T., Sato T., Inokuchi S. Reduction of immunocompetent T cells followed by prolonged lymphopenia in severe sepsis in the elderly. Crit. Care Med. 2013; 41 (3): 810–819. DOI:10.1097/CCM.0b013e318274645f.; De Jager C.P.C., van Wijk P.T.L., Mathoera R.B., de Jongh-Leuvenink J., van der Poll T., Wever P.C. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit. Care. 2010; 14 (5): R192. DOI:10.1186/cc9309.; Forel J.-M., Chiche L., Thomas G., Mancini J., Farnarier C., Cognet C., Guervilly C., Daumas A., Vély F., Xéridat F., Vivier E., Papazian L. Phenotype and functions of natural killer cells in critically-ill septic patients. PLoS One. 2012; 7(12): e50446. DOI:10.1371/journal.pone.0050446.; Souza-Fonseca-Guimaraes F., Parlato M., Fitting C., Cavaillon J.M., Adib-Conquy M. NK cell tolerance to TLR agonists mediated by regulatory T cells after polymicrobial sepsis. J. Immunol. 2012; 188 (12): 5850–5858. DOI:10.4049/jimmunol.1103616.; Grimaldi D., Le Bourhis L., Sauneuf B., Dechartres A., Rousseau C., Ouaaz F., Milder M., Louis D., Chiche J.D., Mira J.P., Lantz O., Pène F. Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med. 2014; 40 (2): 192–201. DOI:10.1007/s00134-013-3163-x.; Venet F., Bohe J., Debard A.L., Bienvenu J., Lepape A., Monneret G. Both percentage of gammadelta T lymphocytes and CD3 expression are reduced during septic shock. Crit Care Med. 2005; 33 (12): 2836–2840. DOI:10.1097/01.CCM.0000189745.66585.AE.; Hotchkiss R.S., Nicholson D.W. Apoptosis and caspases regulate death and inflammation in sepsis. Nat. Rev. Immunol. 2006; 6 (11): 813–822. DOI:10.1038/nri1943.; Chen L., Flies D.B. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat. Rev. Immunol. 2013; 13 (4): 227–242. DOI:10.1038/nri3405.; Zhang Y., Li J., Lou J., Zhou Y., Bo L., Zhu J., Zhu K., Wan X., Cai Z., Deng X. Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients. Crit. Care. 2011; 15 (1): R70. DOI:10.1186/cc10059.; Huang X., Venet F., Wang Y.L., Lepape A., Yuan Z., Chen Y., Swan R., Kherouf H., Monneret G., Chung C.S., Ayala A. PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc. Natl. Acad. Sci USA. 2009; 106 (15): 6303–6308. DOI:10.1073/pnas.0809422106.; Guignant C., Lepape A., Huang X., Kherouf H., Denis L., Poitevin F., Malcus C., Chéron A., Allaouchiche B., Gueyffier F., Ayala A., Monneret G., Venet F. Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit. Care. 2011; 15 (2): R99. DOI:10.1186/cc10112.; Day C.L., Kaufmann D.E., Kiepiela P., Brown J.A., Moodley E.S., Reddy S., Mackey E.W., Miller J.D., Leslie A.J., DePierres C., Mncube Z., Duraiswamy J., Zhu B., Eichbaum Q., Altfeld M., Wherry E.J., Coovadia H.M., Goulder P.J., Klenerman P., Ahmed R., Freeman G.J., Walker B.D. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006; 443 (7109): 350–354. DOI:10.1038/nature05115.; Huang X., Chen Y., Chung C.S., Yuan Z., Monaghan S.F., Wang F., Ayala A. Identification of B7-H1 as a novel mediator of the innate immune/proinflammatory response as well as a possible myeloid cell prognostic biomarker in sepsis. J. Immunol. 2014; 192 (3): 1091–1099. DOI:10.4049/jimmunol.1302252.; Goyert S.M., Silver J. Editorial: PD-1, a new target for sepsis treatment: better late than never. J. Leukoc. Biol. 2010; 88: 225–226. DOI:10.1189/jlb.0410240.; Wick M., Kollig E., Muhr G., Koller M. The potential pattern of circulating lymphocytes TH1/TH2 is not altered after multiple injuries. Arch. Surg. 2000; 135 (11): 1309–1314. DOI:10.1001/archsurg.135.11.1309.; Zajac A.J., Blattman J.N., Murali-Krishna K., Sourdive D.J.D., Suresh M., Altman J.D., Ahmed R. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 1998; 188 (12): 2205–2213. DOI:10.1084/jem.188.12.2205.; Kuethe J.W., Mintz-Cole R., Johnson B.L. 3rd, Midura E.F., Caldwell C.C., Schneider B.S. Assessing the Immune Status of Critically Ill Trauma Patients by Flow Cytometry. Nurs. Res. 2014; 63 (6): 426–434. DOI:10.1097/NNR.0000000000000061.; Monneret G., Debard A.L., Venet F., Bohe J., Hequet O., Bienvenu J., Lepape A. Marked elevation of human circulating CD41CD251 regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med. 2003; 31 (7): 2068– 2071. DOI:10.1097/01.CCM.0000069345.78884.0F.; Kessel A., Bamberger E., Masalha M., Toubi E. The role of T regulatory cells in human sepsis. J. Autoimmun. 2009; 32 (3–4): 211–215. DOI:10.1016/j.jaut.2009.02.014.; Chen K., Zhou Q.X., Shan H.W., Li W.F., Lin Z.F. Prognostic value of CD4(1)CD25(1) Tregs as a valuable biomarker for patients with sepsis in ICU. World. J. Emerg. Med. 2015; 6 (1): 40–43. DOI:10.5847/wjem.j.1920-8642.2015.01.007.; Huang H., Xu R., Lin F., Bao C., Wang S., Ji C., Li K., Jin L., Mu J., Wang Y., Li L., Sun L., Xu B., Zhang Z., Wang F.S. High circulating CD39(+) regulatory T cells predict poor survival for sepsis patients. Int. J. Infect. Dis. 2015; 30: 57–63. DOI:10.1016/j.ijid.2014.11.006.; https://bulletin.tomsk.ru/jour/article/view/2167

Διαθεσιμότητα: https://bulletin.tomsk.ru/jour/article/view/2167
https://doi.org/10.20538/1682-0363-2019-1-18-29

НЕКОТОРЫЕ МЕХАНИЗМЫ ФОРМИРОВАНИЯ УСТОЙЧИВОСТИ К НАРАСТАЮЩЕЙ ГИПОКСИИ НА ФОНЕ СИСТЕМНОЙ ВОСПАЛИТЕЛЬНОЙ РЕАКЦИИ

Θεματικοί όροι: prostaglandins, системная воспалительная реакция, hypoxic apnea, hypoxia, nitric oxide, гипоксическое апноэ, гипоксия, оксид азота, простагландины, systemic inflammatory reaction, 3. Good health

НЕКОТОРЫЕ МЕХАНИЗМЫ ФОРМИРОВАНИЯ УСТОЙЧИВОСТИ К НАРАСТАЮЩЕЙ ГИПОКСИИ НА ФОНЕ СИСТЕМНОЙ ВОСПАЛИТЕЛЬНОЙ РЕАКЦИИ

Θεματικοί όροι: prostaglandins, системная воспалительная реакция, hypoxic apnea, hypoxia, nitric oxide, гипоксическое апноэ, гипоксия, оксид азота, простагландины, systemic inflammatory reaction, 3. Good health

MECHANISMS FOR THE FORMATION OF THE SECONDARY IMMUNOLOGICAL FAILURE IN SEVERE CRANIOCEREBRAL INJURY ; МЕХАНИЗМЫ ФОРМИРОВАНИЯ ВТОРИЧНОЙ ИММУНОЛОГИЧЕСКОЙ НЕДОСТАТОЧНОСТИ ПРИ ТЯЖЕЛОЙ ЧЕРЕПНО-МОЗГОВОЙ ТРАВМЕ

Συγγραφείς: Борщикова, Тамара Ивановна, Епифанцева, Наталья Николаевна, Кан, Сергей Людовикович, Додонов, Максим Владимирович, Филимонов, Сергей Николаевич

Πηγή: Medicine in Kuzbass; Том 17, № 3 (2018): сентябрь; 58-65 ; Медицина в Кузбассе; Том 17, № 3 (2018): сентябрь; 58-65 ; 2588-0411 ; 1819-0901

Θεματικοί όροι: severe craniocerebral injury, systemic inflammatory reaction, immunosupression, cytokines, apoptosis, тяжелая черепно-мозговая травма, системная воспалительная реакция, иммуносупрессия, цитокины, апоптоз

Περιγραφή αρχείου: text/html; application/pdf

Relation: http://mednauki.ru/index.php/MK/article/view/247/488; http://mednauki.ru/index.php/MK/article/view/247/498; http://mednauki.ru/index.php/MK/article/downloadSuppFile/247/269; http://mednauki.ru/index.php/MK/article/downloadSuppFile/247/270; http://mednauki.ru/index.php/MK/article/view/247

Διαθεσιμότητα: http://mednauki.ru/index.php/MK/article/view/247

EFFECTS OF TRANEXAMIC ACID IN THE WIDE RECONSTRUCTIVE SURGERY ON HIP JOINT ; ЭФФЕКТЫ ТРАНЕКСАМОВОЙ КИСЛОТЫ ПРИ РАСШИРЕННЫХ РЕКОНСТРУКТИВНЫХ ВМЕШАТЕЛЬСТВАХ НА ТАЗОБЕДРЕННОМ СУСТАВЕ

Συγγραφείς: T. A. Zhirova, E. B. Makarova, V. A. Rudnov, Т. А. Жирова, Э. Б. Макарова, В. А. Руднов

Πηγή: Messenger of ANESTHESIOLOGY AND RESUSCITATION; Том 13, № 1 (2016); 30-37 ; Вестник анестезиологии и реаниматологии; Том 13, № 1 (2016); 30-37 ; 2541-8653 ; 2078-5658

Θεματικοί όροι: кровопотеря, local inflammatory reaction, system inflammatory reaction, cytokines, loss of blood, эндопротезирование тазобедренного сустава, локальная воспалительная реакция, системная воспалительная реакция, цитокины

Περιγραφή αρχείου: application/pdf

Relation: https://www.vair-journal.com/jour/article/view/76/114; Гусев Е. Ю., Юрченко Л. Н., Черешнев В. А. и др. Методология изучения системного воспаления // Цитокины и воспаление. – 2008. – Т. 7, № 1. – С. 15–23.; Прохоренко Т. С., Саприна Т. В., Лазаренко Ф. Э. и др. Система фактора некроза опухолей-α в патогенезе аутоиммунного сахарного диабета // Бюллетень сиб. мед. – 2011. – № 1. – С. 64–69.; Шевченко Ю. Л., Стойко Ю. М., Замятин М. Н. и др. Кровосберегающий эффект транексамовой кислоты при эндопротезировании коленного сустава // Общ. реаниматология. – 2008. – Т. IV, № 6. – С. 1–4.; Bastian D., Tamburstuen M. V., Lyngstadaas S. P. et al. Systemic and local cytokine kinetics after total hip replacement surgery // Eur. Surg. Res. – 2008. – Vol. 41, № 4. – P. 334–340.; Clementsen T., Krohn C. D., Reikeras O. Systemic and local cytokine patterns during total hip surgery // Scand. J. Clin. Lab. Invest. – 2006. – Vol. 66, № 6. – P. 535–542.; Haghes S. F., Hendricks B. D., Edwards D. R. et al. Lower limb orthopaedic surgery results in changes to coagulation and non-specific inflammatory biomarkers, including selective clinical outcome measures // Eur. J. Med. Res. – 2013. – Vol. 18. – P. 40. http://www.eurjmedres.com/content/18/1/40; Jimenez J. J., Iribarren J. L., Lorente L. et al. Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dosedependent, phase IV clinical trial // J. Cardiothoracic Surg. – 2011. – Vol. 6. – P. 138. http://www.cardiothoracicsurgery.org/content/6/1/138; Jimenez J. J., Iribarren J. L., Lorente L. et al. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial // Crit. Care. – 2007. – Vol. 11, № 6. – R.117 (doi:10.1186/cc6173). – http://ccforum.com/content/11/6/R117; Ker K., Edwards P., Perel P. et al. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis // BMJ. – 2012. – Vol. 344. – e3054–e3067. doi:10.1136/bmj.e3054; Ker K., Prieto-Merino D., Roberts I. Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss // Br. J. Surg. – 2013. – Vol. 100, № 10. – P. 1271–1279.; Levy J. H. Anti-inflammatory strategies and hemostatic agents: old drugs, new ideas // Hematol. Oncol. Clin. North. Am. – 2007. – Vol. 21, № 1. – P. 89–101.; Li Z. J., Fu X., Xing D. et al. Is tranexamic acid effective and safe in spinal surgery? A meta-analysis of randomized controlled trials // Eur. Spine J. – 2013. – Vol. 22. – P. 1950–1957.; Nadler S. B., Hidalgo J. H., Bloch T. Prediction of blood volume in normal human adults // Surgery. – 1962. – Vol. 51, № 2. – P. 224–232.; Ng W. C., Jerath A., Wasowicz M. Tranexamic acid: a clinical review // Anaesthesiology Intensive Therapy. – 2015. – Vol. 47, № 4. – Р. 339–350.; Poeran J., Rasul R., Suzuki S. et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety // BMJ. – 2014. – Vol. 349. – g4829-g4839. doi:10.1136/bmj.g4829.; Vel R., Udupi B. P., Prakash M. V. et al. Effect of low dose tranexamic acid on intra-operative blood loss in neurosurgical patients // Saudi. J. Anaesth. – 2015. – Vol. 9, № 1. – P. 42–48.

Διαθεσιμότητα: https://www.vair-journal.com/jour/article/view/76
https://doi.org/10.21292/2078-5658-2016-13-1-30-37

Cytokines as inducers of postperfusion systemic inflammatory reaction in cardiosurgical patients with different duration of coronary pathology

Συγγραφείς: S. P. Chumakova, O. I. Urazova, V. M. Shipulin, V. V. Novitsky, S. A. Khardikova

Πηγή: Бюллетень сибирской медицины, Vol 16, Iss 4, Pp 260-268 (2018)

Θεματικοί όροι: цитокины, системная воспалительная реакция, ишемическая болезнь сердца, искусственное кровообращение, Medicine

Relation: https://bulletin.ssmu.ru/jour/article/view/1043; https://doaj.org/toc/1682-0363; https://doaj.org/toc/1819-3684; https://doaj.org/article/e80f9f652f934738896607f4624f5ad1

Διαθεσιμότητα: https://doi.org/10.20538/1682-0363-2017-4-260-268
https://doaj.org/article/e80f9f652f934738896607f4624f5ad1

EARLY PULMONARY LESIONS IN INFLUENZA ; РАННИЕ ПОРАЖЕНИЯ ЛЕГКИХ ПРИ ГРИППЕ

Συγγραφείς: S. N. Galkina, L. V. Osidak, L. V. Voloshchuk, M. M. Pisareva, E. G. Golovacheva, A. B. Bubochkin, A. Go, E. V. Naumova, С. Н. Галкина, Л. В. Осидак, Л. В. Волощук, М. М. Писарева, Е. Г. Головачева, А. Б. Бубочкин, А. Го, Е. В. Наумова

Πηγή: CHILDREN INFECTIONS; Том 16, № 2 (2017); 13-22 ; ДЕТСКИЕ ИНФЕКЦИИ; Том 16, № 2 (2017); 13-22 ; 2618-8139 ; 2072-8107 ; 10.22627/2072-8107-2017-16-2

Θεματικοί όροι: коморбидные наслоения, pandemic, pneumonia, peculiarity of clinical presentation, systemic inflammatory reaction, comorbid layering, пандемия, пневмония, системная воспалительная реакция, особенности клиники

Περιγραφή αρχείου: application/pdf

Relation: https://detinf.elpub.ru/jour/article/view/288/281; Nagareddy P., Smyth S. Inflammation and thrombosis in cardiovascular disease. Curr Opin Hematol. 2013; 20(5):457—463.; Итоги пандемии гриппа 2009/2011: противовирусная терапия и тактика лечения (издание 2-ое дополненное) / Ред. Покровский В.И., Киселев О.И., Малеев В.В., Цыбалова Л.М. СПб-М., 2012. 187 с. [The results of an influenza pandemic 2009/2011: antiviral therapy and treatment (published in 2nd Supplement). ed. Pokrovsky V.I., Kiselev O.I., Maleev V.V., Tsybalova L.M. SPb., 2012. 187 p. (In Russian)].; Chowell G., Bertozzi S.M., Colchero M.A., Lopez-Gatell H., AlpucheAranda C., Hernandez M., Miller M.A. Severe Respiratory Disease Concurrent with the Circulation of H1N1 Influenza. N. Engl. J. Med. 2009; 361: 674—679.; Цыбалова Л.М., Карпова Л.С., Комиссаров А.Б., Еропкин М.Ю., Грудинин М.П. Киселев О.И. Эпидемия гриппа A(H1N1)v 2009 г. в России. Вестник РАМН. 2011; 6: 30—36. [Tsybalova L.M., Karpova L.S., Komissarov A.B., Eropkin M. Ju., Grudinin M.P., Kiselev O.I. Influenza A(H1N1)V2009 Epidemic in Russia. Vestnik RAMN. 2011; 6:30—36. (In Russian)].; Азаренок А.А Прочуханова А.Р., Зенин В.В., Люблинская О.Г., Козлова Н.М., Жилинская И.Н. Способность вирусов гриппа и их поверхностных белков стимулировать апоптоз и некроз клеток эндотелия in vitro. Цитология. 2013; 55(6): 430—435. [Azarenok A.A., Prochukhanova A.R., Zenin A.R., Lyublynskaja O.G., Koslova N.M., Zhilinskaja I.N. The ability of influenza viruses and their surface proteins to stimulate apoptosis and necrosis of endothelial cells in vitro he ability of influenza viruses and their surface proteins stimulate. Cytology. 2013; 55(6): 430—435. (In Russian)].; Колобухина Л.В., Щелканов М.Ю., Прошина Е.С., Кириллов И.М., Кружкова И.С., Богданова В.С., Меркулова Л.Н., Федякина И.Т., Самохвалов Е.И., Вартанян Р.В., Бурцева Е.И., Лаврищева В.В., Аристова В.А., Маркова Н.В., Базарова М.В., Бойцов П.В., Маликов В.Е., Келли Е.И., Арсеньева Т.В., Амброси О.Е., Авдеев С.Н., Суточникова О.А., Малышев Н.А., Чучалин А.Г., Львов Д.К. Этиотропная терапия гриппа: уроки последней пандемии. Вестник РАМН. 2011; 5:35—40. [Kolobuhina l., Shchelkanov M., Proshina E., Kirillov I., Kruzhkova I., Bogdanova V., Merkulova l., Fedyakina I., Samohvalov E., Vartanyan R., Burceva E., Lavrishcheva V., Aristova V., Markova N., Bazarova M., Bojcov P., Malikov V., Kelli E., Arseneva T., Ambrosi O., Avdeev S., Sutochnikova O., Malyshev N., Chuchalin A., Lvov D. Ethiological therapy of influenza: the Lessons of the last pandemic. Vestnik RAMS. 2011; 5: 35—40. (In Russian)].; Жилинская И.Н., Лапина Л.А., Оберган Т.Ю. Активация фибринолиза белками вирусов гриппа человека и птиц. Тромбоз, гемостаз и реология. 2011; 4(48):70—78. [Zhilinskaya I.N., Lapin L.A., Bergan T.Yu. Activation of fibrinolysis proteins of influenza viruses of human and birds. Thrombosis, Hemostasis and Rheology. — 2011; 4 (48): 70—78.(In Russian)].; Жилинская И.Н., Азаренок А.А., Ильинская Е.В., Прочуханова А.Р., Воробьев С.Л., Сорокин Е.В., Царева Т.Р. Репродукция вируса гриппа в клетках эндотелия кровеносных сосудов человека. Вопросы вирусологии. 2012; 2: 20—23. [Zhilinskaja I.N., Azarenok A.A., Ilynskaja E.V., Prochukhanova A.R., Vorobjev S.L., Sorokin E.V., Tsareva T.R. Influenza virus reproduction in the endotelian cells of human blood vessels. Problems of Virology. 2012; 2: 20— 23. (In Russian)].; Малый В.П. Грипп А/H1N1 как типичная эмерджентная инфекция (вирусологические, клинико-эпидемологические особенности, лечение и профилактика / Клінічна імунологія. Алергологія. Інфектологія. 2009. 3 (Спецвипуск): 10—22. [Malyi V.P. Influenza A/H1N1 as typical emergent infection (virological, clinical and epidemiological features, treatment and prevention. Clinical immunology. Allergology. Infectology. 2009; 3 (Special issue): 10—22].; Черняев А.Л., Зайратьянц О.В. Патологическая анатомия гриппа A(H1N1). Архив патологии. 2010; 3:70—76. [Chernjajev А.L., Sajratjanz О.V. The pathological anatomy of influenza. The Problems of Patology. 2010; 3: 70—76. (In Russian)].; Bunce P.E., S.M. High, M. Nadjafi, K. Stanley, W.C. Liles, M.D. Christian. Pandemic H1N1 Influenza Infection and Vascular Thrombosis. Clinical Infectious Diseases. 2011; 52(2):e14-e17. 12. Goeijenbier M., van Wissen M., van de Weg C., Jong E., Gerdes V.E., Meijers J.C., Brandjes D.P., van Gorp E.C. Review: Viral infections and mechanisms of thrombosis and bleeding. Journal of Medical Virology. 2012; 84(10):1680—1696.; Kaiser L., Fritz R.S., Straus S.E., Gubareva L., Hayden F.G. Symptom pathogenesis during acute Influenza: interleukin-6 and other cytokine responses. J Med Virol. 2001; 64:262—268.; Клебанов Г.И., Теселкин Ю.О, Бабенкова И.В. и др. Антиоксидантная активность сыворотки крови. Вестн. РАМН. 1999; 2: 15—22. [Klebanov G.I., Teselkin Yu.O, Babenkova I.V. et al. Antioxidant activity of blood serum. Vestnik RAMS. 1999; 2:15—22. (In Russian)].; Сенников С.В., Силков. А.Н. Методы определения цитокинов. Цитокины и воспаление. 2005; 4(1): 22—27. [Sennikov S.V.; Silkov A.N. Methods for determination of cytokines. Сytokines and Inflammation. 2005; 4(1): 22—27. (In Russian)].; Реброва О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA. М.: МедиаСфера, 2002. 312 c. [Rebrova O.Y. Statistical analysis of medical data. Application software package STATISTICA. M., Mass Media, 2002. 312 p. (In Russian)].; Головачева Е.Г. Концептуальные основы иммунного ответа при гриппе, иммунокоррекция в терапии и вакцинопрофилактике: Автореф. дисс. . д.м.н. СПб.,2017. 296 с. [Golovacheva E.G. The conceptual basis of the immune response in influenza, immune correction in therapy and vaccination: Abstract of . PhD Thesis (Medicine). SPb., 2017. 296 p. (In Russian)].; https://detinf.elpub.ru/jour/article/view/288

Διαθεσιμότητα: https://detinf.elpub.ru/jour/article/view/288
https://doi.org/10.22627/2072-8107-2017-16-2-13-22

MECHANISMS FOR THE FORMATION OF THE SECONDARY IMMUNOLOGICAL FAILURE IN SEVERE CRANIOCEREBRAL INJURY

Πηγή: Медицина в Кузбассе, Vol 17, Iss 3, Pp 58-65 (2018)

Θεματικοί όροι: системная воспалительная реакция, цитокины, апоптоз, Medicine, тяжелая черепно-мозговая травма, иммуносупрессия, 3. Good health

Σύνδεσμος πρόσβασης: https://doaj.org/article/2875afcc3cca48a0ae6c9135e244efd7

КОРРЕКЦИЯ СИСТЕМНОЙ ВОСПАЛИТЕЛЬНОЙ РЕАКЦИИ ПРИ КОМПРЕССИОННОЙ ТРАВМЕ МЯГКИХ ТКАНЕЙ У КРЫС ЛОКАЛЬНЫМ ВВЕДЕНИЕМ ГИАЛУРОНОВОЙ КИСЛОТЫ

Θεματικοί όροι: скелетная мышца, цитокины, синдром длительного сдавливания, cytokines, гиалуроновая кислота, hyaluronic acid, rhabdomyolysis, рабдомиолиз, crush syndrome, skeletal muscle, компрессионная травма, системная воспалительная реакция, compression injury, systemic inflammatory response syndrome

Analysis of different therapeutic schemes combining cyclophosphamide and doublestranded DNA preparation for eradication of Krebs-2 primary ascites in mice ; Характеристика режимов терапевтического воздействия циклофосфана и препаратов двуцепочечной ДНК на опухоль Кребс-2, растущую в асцитной форме, приводящих к эрадикации первичного асцита

Συγγραφείς: E. A. Potter, E. V. Dolgova, A. M. Minkevich, V. P. Nikolin, N. A. Popova, Ya. R. Efremov, S. I. Baiborodin, V. A. Rogachev, A. S. Proskurina, A. V. Kozel, O. S. Taranov, V. V. Omigov, E. I. Vereschagin, D. B. Petrov, A. A. Ostanin, E. R. Chernykh, N. A. Kolchanov, S. S. Bogachev, Е. А. Поттер, Е. В. Долгова, А. М. Минкевич, В. П. Николин, Н. А. Попова, Я. Р. Ефремов, С. И. Байбородин, В. А. Рогачев, А. С. Проскурина, А. В. Козел, О. С. Таранов, В. В. Омигов, Е. И. Верещагин, Д. Б. Петров, А. А. Останин, Е. Р. Черных, Н. А. Колчанов, С. С. Богачев

Συνεισφορές: бюджетным проектом № VI.60.1.3

Πηγή: Vavilov Journal of Genetics and Breeding; Том 20, № 1 (2016); 108-124 ; Вавиловский журнал генетики и селекции; Том 20, № 1 (2016); 108-124 ; 2500-3259

Θεματικοί όροι: полиорганная недостаточность, cyclophosphamide (CP), Krebs-2 ascites, tumor-initiating stem cells, remission, NER, homologous recombination, systemic inflammatory reaction, multiple organ failure, циклофосфан, асцит Кребс-2, стволовые инициирующие раковые клетки, ремиссия, гомологичная рекомбинация, системная воспалительная реакция

Περιγραφή αρχείου: application/pdf

Relation: https://vavilov.elpub.ru/jour/article/view/468/757; Беспалов В.Г., Жабин А.А., Стуков А.Н., Беляева О.А., Муразов Я.Г., Семенов А.Л., Коньков С.А., Крылова И.М. Синергизм противоопухолевого действия диоксадэта и цисплатина на модели асцитной опухоли яичника // Сибирский онкологический журнал. 2013. No. 1. C. 42-46. Bespalov V.G., Zhabin A.A., Stukov; A.N., Belyaeva O.A., Murazov Y.G., Semenov A.L., Konkov S.A., Krylova I.M. Synergistic antitumor effect of dioxodate and cisplatin on the model of ovarian ascites tumor // Sibirskii onkologicheskii zhurnal. 2013. No. 1. P. 42-46.; Блохин Н.Н., Переводчикова Н.И. Химиотерапия опухолевых заболеваний. М.: Медицина, 1984. 302 с. Blohin N.N., Perevodchikova N.I. Chemotherapy of neoplastic diseases. M.: Medicina. 302 p. (In Russian).; Волкова О.В., Елецкий Ю.К. Основы гистологии и гистологической техники. М.: Медицина, 1971. 272 с. Volkova O.V., Eleckii Yu.K. The fundamentals of histology and histological technique // M: Medicina, 1971. P. 272. (In Russian).; Гаврилов О.К. Проблемы и гипотезы в учении о свертывании крови // М.: Медицина, 1981. Gavrilov O.K. Problems and hypotheses in the study of blood coagulation. M.: Medicina, 1981. (In Russian).; Долгова Е.В., Рогачев В.А., Николин В.П., Попова Н.А., Лихачева А.С., Алямкина Е.А., Себелева Т.Е., Черных Е.Р., Гельфгат Е.Л., Богачев С.С., Шурдов М.А. Лейкостимулирующее действие фрагментов экзогенной ДНК, защищенных протамином, при вызванной циклофосфаном миелосупрессии мышей // Вопросы онкологии. 2009. Т. 55, No. 6, С. 761-764. Dolgova E.V., Rogachev V.A., Nikolin V.P., Popova N.A., Likhacheva A.S., Sebeleva T.E., Chernykh E.R., Gelfgat E.L., Bogachev S.S., Shurdov M.A. Leukostimulatory effect of exogenous DNA fragments protected by protamine in mica in the case of myelosuppression caused by cyclophosphamide // Voprosy oncologii. 2009. V. 55, No 6, P. 761-764. (In Russian).; Лайт Р.У. Болезни плевры: пер. с англ. М.: Медицина, 1986. С. 106-119. Layt R.U. Pleural disease. M.: Medicina, 1986. P. 106-119. (In Russian).; Поттер Е.А., Долгова Е.В., Минкевич А.М., Ефремов Я.Р., Таранов О.С., Омигов В.В., Николин В.П., Попова Н.А., Проскурина А.С., Верещагин Е.И., Козел А.В., Рогачев В.А., Петров Д.Б., Останин А.А., Черных Е.Р., Колчанов Н.А., Богачев С.С. Терапевтические эффекты воздействия циклофосфана, препаратов двуцепочечной ДНК и их сочетания на раковые клетки асцита Кребс-2 и различные формы трансплантатов // Вавиловский журнал генетики и селекции. 2015а. В печати. Potter Е.А., Dolgova Е.V., Minkevich А.М., Efremov Ya.R., Taranov О.S., Omigov V.V., Nikolin V.P., Popova N.A., Proskurina А.S., Vereschagin Е.I., Kozel А.V., Rogachev V.А., Petrov D.B., Ostanin А.А., Chernykh Е.R., Kolchanov N.А., Bogachev S.S. Therapeutic effects of cyclophosphamide, dsDNA preparations and combinations thereof against Krebs-2 ascites cancer cells and various cancer transplants // Vavilovskii zhurnal genetiki I selekcii. 2015a. (In Russian) (In press).; Стенина М.Б. Спорные вопросы в лечении рака яичников // Онкология: Трудный пациент. 2006. Т. 4. No. 11. С. 9-14. Stenina M.B. Controversial issues in the treatment of ovarian cancer // Oncologiya. 2006. V. 4. No. 11. P. 9-14.; Туаева Н.О., Софронов В.В., Амикеева В.А., Абрамова З.И., Винтер В.Г., Мустафина Д.М., Туточкина К.В. Взаимосвязь концентрации внеклеточной ДНК в плазме крови и содержания антител к нативной ДНК у новорожденных с пневмопатией // Казанский медицинский журнал. 2006. Т. 87. Вып. 4. С. 254-257.; Tuaeva N.O., Sofronov V.V., Amikeeva V.A., Abramova Z.I., Winter V.G., Mustafina D.M., Tutochkina K.V. Interconnection of extracellular DNA concentration in blood plasma and amount of antibodies to native DNA in newborns with pneumopathy // Kazanskii medicinskii zhurnal. 2006. V. 87. No. 4. P. 254-257. (In Russian).; Alyamkina E.A., Dolgova E.V., Likhacheva A.S., Rogachev V.A., Sebeleva T.E., Nikolin V.P., Popova N.A., Orishchenko K.E., Strunkin D.N., Chernykh E.R., Zagrebelniy S.N., Bogachev S.S., Shurdov M.A. Combined therapy with cyclophosphamide and DNA preparation inhibits the tumor growth in mice // Genet. Vaccines Ther. 2009. V. 7(1). No. 12. DOI:10.1186/1479-0556-7-12.; Alyamkina E.A., Dolgova E.V., Likhacheva A.S., Rogachev V.A., Sebeleva T.E., Nikolin V.P., Popova N.A., Kiseleva E.V., Orishchenko K.E., Sakhno L.V., Gel’fgat E.L., Ostanin A.A., Chernykh E.R., Zagrebelniy S.N., Bogachev S.S., Shurdov M.A. Exogenous allogenic fragmented double-stranded DNA is internalized into human dendritic cells and enhances their allostimulatory activity // Cell Immunol. 2010a. V. 262. P. 120-126. DOI:10.1016/j.cellimm.2010.01.005.; Alyamkina E.A., Leplina O.Y., Sakhno L.V., Chernykh E.R., Ostanin A.A., Efremov Y.R., Shilov A.G., Proskurina A.S., Orishchenko K.E., Dolgova E.V., Rogachev V.A., Nikolin V.P., Popova N.A., Zagrebelniy S.N., Bogachev S.S., Shurdov M.A. Effect of double-stranded DNA on maturation of dendritic cells in vitro // Cell Immunol. 2010b. V. 266. P. 46-51. DOI:10.1016/j.cellimm.2010.08.011.; Alyamkina E.A., Nikolin V.P., Popova N.A., Dolgova E.V., Proskurina A.S., Orishchenko K.E., Efremov Y.R., Chernykh E.R., Ostanin A.A., Sidorov S.V., Ponomarenko D.M., Zagrebelniy S.N., Bogachev S.S., Shurdov M.A. A strategy of tumor treatment in mice with doxorubicin-cyclophosphamide combination based on dendritic cell activation by human double-stranded DNA preparation // Genet. Vaccines Ther. 2010c. V. 8(1). No. 7. DOI:10.1186/1479-0556-8-7.; Alyamkina E.A., Leplina O.Y., Ostanin A.A., Chernykh E.R., Nikolin V.P., Popova N.A., Proskurina A.S., Gvozdeva T.S., Dolgova E.V., Orishchenko K.E., Rogachev V.A., Sidorov S.V., Varaksin N.A., Ryabicheva T.G., Bogachev S.S., Shurdov M.A. Effects of human exogenous DNA on production of perforin-containing CD8+ cytotoxic lymphocytes in laboratory setting and clinical practice // Cell Immunol. 2012. V. 276. P. 59-66. DOI:10.1016/j.cellimm.2012.04.004.; Alyamkina E.A., Nikolin V.P., Popova N.A., Minkevich A.M., Kozel A.V., Dolgova E.V., Efremov Y.R., Bayborodin S.I., Andrushkevich O.M., Taranov O.S., Omigov V.V., Rogachev V.A., Proskurina A.S., Vereschagin E.I., Kiseleva E.V., Zhukova M.V., Ostanin A.A., Chernykh E.R., Bogachev S.S., Shurdov M.A. Combination of cyclophosphamide and double-stranded DNA demonstrates synergistic toxicity against established xenografts // Cancer Cell Int. 2015. V. 15. No. 32. DOI:10.1186/s12935-015-0180-6.; Anker P., Mulcahy H., Chen X.Q., Stroun M. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients // Cancer Metastasis Rev. 1999. V. 18. No. 1. P. 65-73.; Bleiblo F., Michael P., Brabant D., Ramana C.V., Tai T., Saleh M., Parrillo J.E., Kumar A., Kumar A. The role of immunostimulatory nucleic acids in septic shock // Int. J. Clin. Exp. Med. 2012. V. 5. ISSN:1940-5901/IJCEM1112008.; Brenner D.E. Intraperitoneal chemotherapy: a review // J. Clin. Oncol. 1986. V. 4. No. 7. P. 1135-1147.; Decker P., Wolburg H., Rammensee H.G. Nucleosomes induce lymphocyte necrosis // Eur. J. Immunol. 2003. V. 33. No. 7. P. 1978–1987. DOI:10.1002/eji.200323703.; Dolgova E.V., Proskurina A.S., Nikolin V.P., Popova N.A., Alyamkina E.A., Orishchenko K.E., Rogachev V.A., Efremov Y.R., Dubatolova T.D., Prokopenko A.V., Chernykh E.R., Ostanin A.A., Taranov O.S., Omigov V.V., Zagrebelniy S.N., Bogachev S.S., Shurdov M.A. “Delayed death” phenomenon: A synergistic action of cyclophosphamide and exogenous DNA // Gene. 2012. V. 495. No. 2. P. 134-145. DOI:10.1016/j.gene.2011.12.032.; Dolgova E.V., Efremov Y.R., Orishchenko K.E., Andrushkevich O.M., Alyamkina E.A., Proskurina A.S., Bayborodin S.I., Nikolin V.P., Popova N.A., Chernykh E.R., Ostanin A.A., Taranov O.S., Omigov V.V., Minkevich A.M., Rogachev V.A., Bogachev S.S., Shurdov M.A. Delivery and processing of exogenous double-stranded DNA in mouse CD34+ hematopoietic progenitor cells and their cell cycle changes upon combined treatment with cyclophosphamide and double-stranded DNA // Gene. 2013. V. 528. No. 2. P. 74-83. DOI:10.1016/j.gene.2013.06.058.; Dolgova E.V., Alyamkina E.A., Efremov Y.R., Nikolin V.P., Popova N.A., Tyrinova T.V., Kozel A.V., Minkevich A.M., Andrushkevich O.M., Zavyalov E.L., Romaschenko A.V., Bayborodin S.I., Taranov O.S., Omigov V.V., Shevela E.Y., Stupak V.V., Mishinov S.V., Rogachev V.A., Proskurina A.S., Mayorov V.I., Shurdov M.A., Ostanin A.A., Chernykh E.R., Bogachev S.S. Identification of cancer stem cells and a strategy for their elimination // Cancer Biol. Ther. 2014. V. 15. No. 10. P. 1378-1394. DOI:10.4161/cbt.29854.; Garlatti V., Chouquet A., Lunardi T., Vives R., Paidassi H., Lortat-Jacob H., Thielens N.M., Arlaud G.J., Gaboriaud C. Cutting edge: C1q binds deoxyribose and heparin sulfate through neighboring sites of its recognition domain // J. Immunol. 2010. V. 185. No. 2. P. 808-812. DOI:10.4049/jimmunol.1000184.; Garcia-Olmo D., Garcia-Olmo D.C., Ontanon J., Martinez E. Horizontal transfer of DNA and the “genometastasis hypothesis” // Blood. 2000. V. 95. № 2. P. 724-725.; Gupta P.B., Fillmore C.M., Jiang G., Shapira S.D., Tao K., Kuperwasser C., Lander E.S. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells // Cell. 2011. V. 146. No. 4. P. 633-644. DOI:10.1016/j.cell.2011.07.026.; Jahr S., Hentze H., Englisch S., Hardt D., Fackelmayer F.O., Hesch R.D., Knippers R. DNA fragments in the blood plasma of cancer patients quantitations and evidence for their origin from apoptotic and necrotic cells // Cancer Res. 2001. V. 61. No. 4. P. 1659-1665.; Jiang H., Cooper B., Robey F.A., Gewurz H. DNA binds and activates complement via residues 14-26 of the human C1q A chain // J. Biol. Chem. 1992. V. 267. No. 35. P. 25597-25601.; Kaczorowski D.J., Scott M.J., Pibris J.P., Afrazi A., Nakao A., Edmonds R.D., Kim S., Kwak J.H., Liu Y., Fan J., Billiar T.R. Mammalian DNA is an endogenous danger signal that stimulates local synthesis and release of complement factor B // Mol. Med. 2012. V. 18. No. 1. P. 851–860. DOI:10.2119/molmed.2012.00011.; Laktionov P.P., Tamkovich S.N., Rykova E.Y., Bryzgunova O.E., Starikov A.V., Kuznetsova N.P., Sumarokov S.V., Kolomiets S.A., Sevostianova N.V., Vlassov V.V. Extracellular circulating nucleic acids in human plasma in health and disease // Nucleosides Nucleotides Nucleic Acids. 2004. V. 23. No. 6-7. P. 879-883.; Parsons D.F., Marko M., Braun S.J., Wansor K.J. Ascites tumor invasion of mouse peritoneum studied by high-voltage electron microscope stereoscopy // Cancer Res. 1982. V. 42. No. 11. P. 4574-4583.; Tissot B., Daniel R., Place C. Interaction of the C1 complex of the complement with sulfated polysaccharide and DNA probed by single molecule fluorescence microscopy // Eur. J. Biochem. 2003. V. 270. No. 23. P. 4714-4720.; https://vavilov.elpub.ru/jour/article/view/468

Διαθεσιμότητα: https://vavilov.elpub.ru/jour/article/view/468
https://doi.org/10.18699/VJ15.117

Eradication of Krebs-2 primary ascites via a single-injection regimen of cyclophosphamide and double-stranded DNA ; Режим однократной инъекции препарата двуцепочечной ДНК после каждой инъекции циклофосфана, приводящий к эрадикации первичного асцита Кребс-2

Συγγραφείς: E. A. Potter, E. V. Dolgova, A. M. Minkevich, V. P. Nikolin, N. A. Popova, Ya. R. Efremov, S. I. Baiborodin, V. A. Rogachev, A. S. Proskurina, O. S. Taranov, E. I. Vereschagin, A. A. Ostanin, E. R. Chernykh, N. A. Kolchanov, S. S. Bogachev, Е. А. Поттер, Е. В. Долгова, А. М. Минкевич, В. П. Николин, Н. А. Попова, Я. Р. Ефремов, С. И. Байбородин, В. А. Рогачев, А. С. Проскурина, О. С. Таранов, Е. И. Верещагин, А. А. Останин, Е. Р. Черных, Н. А. Колчанов, С. С. Богачев

Πηγή: Vavilov Journal of Genetics and Breeding; Том 20, № 5 (2016); 716-722 ; Вавиловский журнал генетики и селекции; Том 20, № 5 (2016); 716-722 ; 2500-3259

Θεματικοί όροι: полиорганная недостаточность, cyclophosphamide, Krebs-2 ascites, tumor-initiating cancer stem cells, repair, remission, NER, homologous recombination, systemic inflammatory reaction, multiple organ failure, циклофосфан, асцит Кребс-2, стволовые инициирующие раковые клетки, репарация, ремиссия, гомологичная рекомбинация, системная воспалительная реакция

Περιγραφή αρχείου: application/pdf

Relation: https://vavilov.elpub.ru/jour/article/view/820/842; Alyamkina E.A., Dolgova E.V., Likhacheva A.S., Rogachev V.A., Sebeleva T.E., Nikolin V.P., Popova N.A., Orishchenko K.E., Strunkin D.N., Chernykh E.R., Zagrebelniy S.N., Bogachev S.S., Shurdov M.A. Combined therapy with cyclophosphamide and DNA preparation inhibits the tumor growth in mice. Genet Vaccines Ther. 2009;7(1):12. DOI 10.1186/1479-0556-7-12.; Alyamkina E.A., Dolgova E.V., Likhacheva A.S., Rogachev V.A., Sebeleva T.E., Nikolin V.P., Popova N.A., Kiseleva E.V., Orishchenko K.E., Sakhno L.V., Gel’fgat E.L., Ostanin A.A., Chernykh E.R., Zagrebelniy S.N., Bogachev S.S., Shurdov M.A. Exogenous allogenic fragmented double-stranded DNA is internalized into human dendritic cells and enhances their allostimulatory activity. Cell. Immunol. 2010a;262(2):120-126.; Alyamkina E.A., Leplina O.Y., Sakhno L.V., Chernykh E.R., Ostanin A.A., Efremov Y.R., Shilov A.G., Proskurina A.S., Orishchenko K.E., Dolgova E.V., Rogachev V.A., Nikolin V.P., Popova N.A., Zagrebelniy S.N., Bogachev S.S., Shurdov M.A. Effect of doublestranded DNA on maturation of dendritic cells in vitro. Cell. Immunol. 2010b;266(1):46-51.; Alyamkina E.A., Nikolin V.P., Popova N.A., Dolgova E.V., Proskurina A.S., Orishchenko K.E., Efremov Y.R., Chernykh E.R., Ostanin A.A., Sidorov S.V., Ponomarenko D.M., Zagrebelniy S.N., Bogachev S.S., Shurdov M.A. A strategy of tumor treatment in mice with doxorubicin- cyclophosphamide combination based on dendritic cell activation by human double- stranded DNA preparation. Genet. Vaccines Ther. 2010c;8:7. DOI 10.1186/1479-0556-8-7.; Alyamkina E.A., Nikolin V.P., Popova N.A., Minkevich A.M., Kozel A.V., Dolgova E.V., Efremov Y.R., Bayborodin S.I., Andrushkevich O.M., Taranov O.S., Omigov V.V., Rogachev V.A., Proskurina A.S., Vereschagin E.I., Kiseleva E.V., Zhukova M.V., Ostanin A.A., Chernykh E.R., Bogachev S.S., Shurdov M.A. Combination of cyclophosphamide and double-stranded DNA demonstrates synergistic toxicity against established xenografts. Cancer Cell Int. 2015;15:32. DOI 10.1186/s12935-015-0180-6.; Dolgova E.V., Alyamkina E.A., Efremov Y.R., Nikolin V.P., Popova N.A., Tyrinova T.V., Kozel A.V., Minkevich A.M., Andrushkevich O.M., Zavyalov E.L., Romaschenko A.V., Bayborodin S.I., Taranov O.S., Omigov V.V., Shevela E.Y., Stupak V.V., Mishinov S.V., Rogachev V.A., Proskurina A.S., Mayorov V.I., Shurdov M.A., Ostanin A.A., Chernykh E.R., Bogachev S.S. Identification of cancer stem cells and a strategy for their elimination. Cancer Biol. Ther. 2014;15(10):1378- 1394. DOI 10.4161/cbt.29854.; Dolgova E.V., Rogachev V.A, Nikolin V.P., Popova N.A., Likhacheva A.S., Alyamkina E.A., Sebeleva T.E., Chernykh Е.R., Gelfgat E.L., Bogachev S.S., Shurdov M.A. The leukocyte- stimulating action of protamine-protected exogenous DNA in -myelosuppression induced in mice by cyclophosphane. Voprosy onkologii = Problems in Oncology. 2009;55(6):761-764. (in Russian); Peshkova I.V., Bogachev S.S., Drobyazgin E.A., Chikinev Y.V., Mitrofanov I.M., Piontkovskaya K.A., Vereschagin E.I. Effect of glutamine on the nucleic acids exchange during the perioperative period in reconstructive esophagus surgery. J. Nutr. Health Food Eng. 2015;2(4):00058. DOI 10.15406/jnhfe.2015.02.00058.; Potter Е.А., Dolgova Е.V., Minkevich А.М., Efremov Y.R., Taranov О.S., Omigov V.V., Nikolin V.P., Popova N.A., Proskurina А.S., Vereschagin Е.I., Kozel А.V., Rogachev V.А., Petrov D.B., Ostanin А.А., Chernykh Е.R., Kolchanov N.А., Bogachev S.S. Therapeutic effects of cyclophosphamide, dsDNA preparations and their combinations against Krebs-2 ascites cancer cells and various cancer transplants. Vavilovskii Zhurnal Genetiki i Selektsii = Vavilov Journal of Genetics and Breeding. 2016a;20(1):96-107. DOI 10.18699/VJ15.116. (in Russian); Potter Е.А., Dolgova Е.V., Minkevich А.М., Nikolin V.P., Popova N.A., Efremov Y.R., Baiborodin S.I., Rogachev V.А., Proskurina А.S., Kozel А.V., Taranov О.S., Omigov V.V., Vereschagin Е.I., Petrov D.B., Ostanin А.А., Chernykh Е.R., Kolchanov N.А., Bogachev S.S. Analysis of different therapeutic schemes combining cyclophosphamide and double-stranded DNA preparations for eradication of Krebs-2 primary ascites in mice. Vavilovskii Zhurnal Genetiki i Selektsii = Vavilov Journal of Genetics and Breeding. 2016b;20(1):108-124. DOI 10.18699/VJ15.117. (in Russian); Scharovsky O.G., Mainetti L.E., Rozados V.R. Metronomic chemotherapy: changing the paradigm that more is better. Curr. Oncol. 2009; 16(2):7-15.; https://vavilov.elpub.ru/jour/article/view/820

Διαθεσιμότητα: https://vavilov.elpub.ru/jour/article/view/820
https://doi.org/10.18699/VJ16.161